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Abstract 
 
The endocannabinoid system is an important modulatory system, which is involved in the regulation of 
many physiological processes including learning and memory. The type 1 cannabinoid receptor (CB1) is 
abundant in the brain where it is mainly expressed on neurons. Moreover, it has also been shown that CB1 
receptor is also present in astrocytes. Although astrocytes were long thought to be mainly supportive cells, it is 
now recognized that they play key roles in bidirectional communication with neurons, thereby modulating 
important aspects of synaptic transmission and plasticity. Recent key studies show that exogenous activation of 
hippocampal astroglial CB1 by natural or synthetic CB1 agonists impairs working memory in mice and induces 
alterations of synaptic plasticity. However, the endogenous role of astroglial CB1 receptors in vivo is unknown. 
Unpublished data from the host laboratory indicate that CB1 receptor in astrocytes is necessary for object 
recognition memory likely through a mechanism involving hippocampal D-serine, a co-agonist of the NMDA 
receptor. However, the neuronal mechanism by which astroglial CB1 receptor control this memory function is 
unknown. As long term changes in hippocampal synaptic plasticity are thought to participate in object 
recognition memory, we proposed to assess the role of CB1 receptor located in astrocytes in hippocampal 
synaptic plasticity. We used in vivo electrophysiology combined with conditional mutant mice lacking type-1 
cannabinoid receptors and pharmacological approaches to investigate the role of astroglial CB1 receptor on 
synaptic functionality of the CA3-CA1 Schaffer Collateral Pathway in the hippocampus. Our results indicate 
that astroglial CB1 receptor is crucial for induction and maintenance of hippocampal NMDAR-dependent long 
term potentiation in the CA3-CA1 Shaffer Collateral pathway. We demonstrated that systemically 
administration of D-serine is also able to rescue the impairment in hippocampal NMDAR-dependent long term 
potentiation exhibited in mice lacking astroglial CB1 receptors. Altogether these results boost the growing 
concept that endocannabinoid system is crucial for neuronal-glial bidirectional communication, participating in 
the astrocytic-dependent regulation of synaptic plasticity in hippocampal glutamatergic synapses. 
 
Keywords: Astroglial CB1 Receptor – D-Serine – Synaptic Plasticity – Learning and Memory –         in vivo 
Electrophysiology 
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Resumo 
 
O Sistema Endocanabinóide é um importante sistema modulador envolvido na regulação de funções 
fisiológicas como a aprendizagem e a memória. O receptor canabinóide tipo 1 (CB 1) encontra-se 
abundantemente expresso no encéfalo primariamente em neurónios. Recentemente, a sua presença foi 
demonstrada em astrócitos. Os astrócitos, aos quais se atribuem classicamente funções de suporte neuronal, 
participam intrinsecamente na comunicação bidireccional com neurónios exercendo deste modo uma modulação 
em fenómenos de transmissão e plasticidade sináptica. Estudos recentes mostram que a activação exógena de 
CB1 em astrócitos do hipocampo, pela acção de agonistas naturais e sintéticos, prejudica a memória de trabalho 
em ratinhos e induz ainda alterações na plasticidade sináptica. Contudo, a função endógena deste receptor em 
astrócitos in vivo é desconhecida. Dados não publicados do laboratório de acolhimento indicam que o receptor 
CB1 em astrócitos é necessário para memória de reconhecimento de objectos possivelmente através de um 
mecanismo envolvendo D-Serina, um co-agonista dos receptores de NMDA. Contudo, é ainda desconhecido o 
mecanismo envolvendo os CB1 em astrócitos e a formação deste tipo de memória. Devido ao facto das 
alterações de longo prazo na plasticidade sináptica no hipocampo serem assumidas como um potencial 
mecanismo de formação memória de reconhecimento de objectos, tencionamos desvendar o papel do CB1 em 
astrócitos nesses mesmos fenómenos de plasticidade sináptica. Para alcançar os nossos objectivos, usamos 
electrofisiologia in vivo combinada com tratamentos farmacológicos em ratinhos mutantes que não expressam o 
CB1 em astrócitos de modo a investigar o papel deste receptor na funcionalidade sináptica da região CA3-CA1 
Schaffer Collateral no hipocampo. Os nossos resultados indicam que os receptores CB1 em astrócitos são 
cruciais para a indução e a manutenção de uma potenciação de longa duração que é dependente dos receptores 
NMDA. Demonstramos ainda que a administração sistémica de D-Serina é capaz de recuperar a perda da 
capacidade de potenciação exibida ratinhos que não expressam CB1 em astrócitos. Em suma, os nossos 
resultados reforçam o crescente conceito de que o sistema Endocanabinóide é essencial para a comunicação 
bidireccional entre neurónios e glia, participando na regulação da plasticidade sináptica dependente de astrócitos 
nas sinapses glutamatérgicas do hipocampo.   
 
Palavras-chave: Receptor CB1 em astrócitos – D-Serina – Plasticidade Sináptica – Aprendizagem e Memória – 
Electrofisiologia in vivo 
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Chapter I – Introduction 
Part I – The endocannabinoid system and the brain 
 
Part I | Section 1 – Historical considerations and general characterization 
 
Cannabis sativa, commonly known by Marijuana, is known to exert a huge array of 
physiological and psychotropic effects recognized and described by the humankind since, at least, 
2000 BC. Throughout the history archaeological evidence shows that Cannabis diffused broadly in 
China, India and Arabia even reaching Africa and South America (Mechoulam and Parker, 2012). Its 
introduction in Europe dates the 19
th 
century probably by the Napoleonic Armies that returned from 
Mesopotamian territories. After this period in which Cannabis became quite known to Europeans, 
O’Shaughnessy and Moreau did important studies on the subject. The first, a medical officer of the 
British Army in Calcutta, described therapeutic and narcotic properties assed in humans. The second, a 
psychiatrist, described in a book called “Hashish and Mental Illness” many effects of the 
administration of Cannabis to human test subjects (Mechoulam and Parker, 2012). These effects, that 
could random from feeling of happiness, excitement, illusions and hallucinations, helped to provide 
important medical data on the effects of cannabis consumption in humans.  
Cannabis consumption is frequently associated with recreational purposes and has never been 
clearly assumed to be harmful to health in the long term usage (Murray et al., 2007). Although these 
apparent non harmful effects of cannabis, its consumption properties are known to cause several 
physiological and behavioral alterations such as cognitive impairments (i.e., working memory 
impairments), discoordination, sleepiness, mood alterations (such as  euphoria or dysphoria) among 
other effects (Childers and Breivogel, 2000). Despite cannabis effects on human physiology, medical 
research on the subject was very poor and in the beginning of the 20
th
 century its usage, both medical 
and recreational, was very low both in Europe and North America (Mechoulam and Parker, 2013). 
Moreover, anti-cannabis laws that were created from 1940 to 1960 made this plant almost inaccessible 
to research groups in North America. Paradoxically, at the same time its recreational usage exploded in 
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Europe and North America, making it again an interesting subject of study (Mechoulam and Parker, 
2013). 
The first breakthrough in understanding Cannabis effects came in 1964 with the identification 
and characterization of Cannabis sativa’s main active compound: Δ9-tetrahidrocanabinol (THC) 
(Gaoni and Mechoulam, 1964). This milestone, achieved by Gaoni and Mecholuam, and the 
subsequent artificial synthesis of THC (Mechoulam et al., 1967) for research purposes opened a new 
window into cannabinoid research. Interestingly, although the existence of more than 60 cannabis 
constituents with very similar structural and physical properties only THC shows major mood-altering 
effects (Mechoulam and Parker, 2013). 
This availability of THC for research purposes allowed more precise quantitative studies of its 
effects in animals. Soon many of the physiological and psychoactive effects of cannabis were 
successfully replicated in THC studies allowing the correlation between Cannabis consumption and, 
for example, hypolocomotion, hypothermia, analgesia, catalepsy (these last four effects, together, are 
called tetrad), stress reactivity (Maldonado et al., 2011), anticonvulsant effects (Wallace et al., 2001), 
regulation of food intake (Di Marzo and Matias, 2005). 
The discovery of THC and its lipophilic structure suggested that its effects were through a 
nonspecific membrane associated mechanism (Mechoulam and Parker, 2012). The first data 
suggesting a different model, a more specific one, appeared only in 1984. In this year, Howlett and 
colleagues reported that cannabinoids decreased cyclic Adenosine Monophosphate (cAMP) in 
neuroblastoma cell cultures H thus suggesting a mechanism dependent on the inhibition of the 
Adenylate Cyclase (AC) through a G protein. Later in 1988, through immunochemical and radio 
ligand binding procedures, the same research group led by Howlett reported the existence of binding 
sites in the brain (Devane et al., 1988). Two year later the Cannabinoid Receptor 1 (CB1) is finally 
cloned (Matsuda et al., 1990) and the research on CB1 knows a huge explosion. In 1993, Munro et al. 
described a second cannabinoid receptor (CB2), this time in the spleen (Munro et al., 1993) and 
although CB1 was mainly found in the brain, the second receptor was mainly found the immune 
system (Kano et al., 2009). The discovery of the cannabinoid receptors propelled a new search for its 
purpose. The receptors, as a natural part of the body’s physiology, were thought to respond to some 
kind of molecule that could be produced endogenously. This hypothesis led to the discovery of 
endogenous agonists of these receptors: the endocannabinoids. From these new signaling molecules, 
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the very first to be reported was N-arachidonoylethanolamine (AEA, Anandamide) (Devane et al, 
1992) and the second was 2-Arachidonoylglycerol (2-AG) (Mechoulam et al., 1995). Due to their 
lipophilicity their effects were thought to be mediated locally and strictly dependent on the location of 
the receptors and/or production sites (Di Marzo, 2011). After the discovery of the endocannabinoids in 
the early 90s, the biochemical pathways for their biosynthesis and degradation were reported later, in 
1994, by Di Marzo and colleagues. Altogether, the cannabinoid receptors, the endogenous agonists and 
the catabolic/anabolic pathways form a new modulatory system: the endocannabinoid system. 
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Part I | Section 2 - The Cannabinoid Receptors 
 
Section 2.1 – Characterization and pharmacology 
 
The endocannabinoid system comprises two main well identified and characterized receptors: 
CB1 and CB2 (Figure 1). Both belong to the Class 11 rhodopsin-like family of G-protein coupled 
receptors (GPCR) (Emmanuel et al., 2006) (Figure 1) and both are composed by 7-transmembrane 
domains. These receptors, the most abundant G-protein coupled receptors in the body (Herkenham et 
al. 1990), exert their molecular effect mainly through a G protein inhibitory component which leads to: 
1) the inhibition of the activity of Adenylate Cyclase; 2) the stimulation of the Mitogen-Activated 
Protein Kinases (MAPK) pathway; 3) the inhibition of the N and Q voltage-activated calcium 
channels; 4) the stimulation of the potassium inwardly rectifying channels (Emmanuel et al., 2006; 
Howlett, 2002; McAllister et al., 2002).  
 
 
FIGURE 1 – GRAPHICAL REPRESENTATION OF CANNABINOID RECEPTOR 1 AND 2 (adapted from 
http://druglibrary.org/Schaffer/Library/studies/iom/iom2.htm - last access in 24/07/2013). 
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Both receptors show an overall amino acid similarity close to 48% (Mechoulam and Parker, 
2013) where CB1 has more 72 additional amino acids in N-terminal region, 15 more residues in the 
third extracellular loop and 13 additional residues in the C-terminal region. Additionally, the highest 
difference between the structures occurs in the transmembrane regions TM2, TM3, TM5 and TM6 
(Svízenská et al., 2008). 
Although CB1 is mainly expressed in Central Nervous System (CNS) it was also reported in 
other several areas, such in the cardiovascular system, reproductive system and the gastrointestinal 
tract (Kano et al., 2009).  Furthermore, it was estimated that in a population of CB1 receptors, 70% 
occur in an inactive state where the remaining 30% are in the active state (Onaivi et al, 2005). 
Although broadly expressed throughout the body, it’s preferentially present in the brain and the spinal 
cord (Kano et al., 2009).  
In the other hand, CB2 doesn’t have its main expression in the brain. This receptor, firstly 
described in the macrophages from the marginal zone of spleen (Munro et al., 1993), has also been 
reported in the skin, the tonsil, the spleen and the thymus. Concerning the brain and more recently, 
CB2 was observed in microglial cells with a putative role in a general brain protective system 
(Mechoulam and Parker, 2012).   
Although the classical cannabinoid receptors (CB1 and CB2) are accepted as the main drivers 
of the cannabinoid system, they are not the only ones responding to endocannabinoids. In experiments 
carried out on brain cells from transgenic mice lacking both CB1 and CB2 receptors, Anandamide 
could still induce a pharmacological effect leading to the idea of the existence of other putative 
cannabinoid receptors (Breivogel et al., 2001). After these findings, further research proposed the 
Transient Receptor Potential Vanilloid type-1 (TRPV1) as the best non-CB1/CB2 receptor for AEA 
(reviewed in Starowicz et al., 2007 and Petrocellis et al., 2009). The TRPV1 is a calcium channel that 
is gated by capsaicin, low pH, and endogenous cannabinoid agonists (Szallasi and Blumberg, 1999; 
Starowicz et al., 2007; Wong et al., 2009). TRPV1 brain expression is observed in areas such as the 
hippocampus, cortex, cerebellum, olfactory bulb, mesencephalon and the hindbrain (Tóth et al., 2005).  
Also two other GPCRs, the G protein-coupled receptor  55  (GPR55)  and  the  G  protein-coupled  
receptor  119  (GPR119),  emerged  as  novel potential cannabinoid receptors (Brown, 2007). The 
GPR55 couples a Gα13 and has affinity for endogenous, plant and synthetic cannabinoids. It is 
expressed in the body (mainly in the spleen, adrenal glands and gastrointestinal tract) and in the brain, 
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especially in the caudate nucleus and putamen with minor a presence in hippocampus, thalamus, pons, 
cerebellum and frontal cortex (Kano et al., 2009). In the other hand, the GPR119 (also coupled to Gα) 
share some similarities to the classical cannabinoid receptors. They are more present in the pancreas 
and also in the gastrointestinal tract both in humans and in mice. Their putative physiological role 
involves the control of glucose homeostasis through modulation of insulin secretion (Kano et al., 
2009).  
The design of several molecules that could interact specifically with the ECS was a key event 
to study the specific roles of the several components concerning the complex function of this system 
(Figure 2). Among the effects and potential therapeutic uses, some of these synthetic molecules are 
being use as anti-obesity and anti-tumor agents and as chronic pain reducing agents (Di Marzo et al., 
2004). HU-210, an enantiomerically pure THC analogue, is one of these synthetic analogues that gave 
powerful insights on THC’s mechanism of action. It further labeling to generate tritium (HU-245) and 
the synthesis of CP-55.245 led to the identification of the cannabinoid receptors (Di Marzo et al., 
2004). In the other hand, compounds that are able to inhibit or reverse the effect of endocannabinoids 
are also important to the cannabinoid receptor’s function. Examples are the SR 141716A, commonly 
known as Rimonabant (Rinaldi-Carmona et al., 1994), the AM251 (Gatley et al., 1996) and the 
AM281 (Lan et al., 1999). Other important compounds, such as URB-597, do not act directly in the 
receptors but on the availability of endocannabinoids levels through the inhibition of their degradation 
(Di Marzo et al., 2004). Altogether these pharmacological tools are of the most importance to 
understand the physiological function of the ECS. 
De Petrocellis et al., (2009), describe the endocannabinoid system as a pleiotropic and locally 
acting pro-homeostatic signaling system activated ‘on demand’ following perturbation of cell 
homeostasis. It’s a system that is constantly being updated since new molecules, potential receptors, 
new enzymes and more intracellular cascades are being discovered. The new molecular tools, along 
with new synthetic compounds that are able to play a specific role in the pathways, offer the possibility 
to investigate even further new possibilities and gather important insight that can boost medical 
research on the subject. 
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FIGURE 2 - CHEMICAL STRUCTURES OF DRUGS ACTING ON ENDOCANNABINOID SYSTEM (Adapted 
from De Petrocellis et al., 2004; Di Marzo et al., 2004; Di Marzo, 2008)  
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Section 2.2 – Distribution of the CB1 in the brain 
 
The CB1 can be found mainly, but not only, in the neurons of the CNS. CB1 proteins and 
mRNA transcripts are present in brain areas which are responsible for several vital and important 
functions such as learning and memory, pain perception, reward, energy and metabolism, among 
others (Köfalvi, 2008). Due to the nature of this introduction and research objectives present in this 
thesis, the aspects of the CB1 distribution will be focused mainly in the hippocampus (Figure 3A and 
3C). 
FIGURE 3 - DISTRIBUTION OF CB1  RECEPTORS IN THE CENTRAL NERVOUS SYSTEM OF ADULT MICE. CB1 distribution pattern through 
immunolabeling in a parasagittal (A) and coronal (B,C) wild-type and parasagittal CB1-KO (D) mice. High CB1 immunoreactivity, among 
other areas, is presented in structures belonging to the Medial Temporal Lobe such as:  hippocampus (Hi), dentate gyrus (DG) and entorhinal 
cortex (Ent). High CB1 immunoreactivity can be also found in the anterior olfactory nucleus (AON, A), neocortex (A-C), caudate putamen 
(CPu, A-C), thalamus (Th, A,C) basolateral (BLA) and central (Ce) amygdaloid nuclei (C), cerebellum (Cb, A) and spinal cord (E).  M1, 
primary motor cortex; S1, primary somatosensory cortex; V1, primary visual cortex; Cg, cingulate cortex; Ent, entorhinal cortex; DG, dentate 
gyrus; NAc, nucleus accumbens, GP, globus pallidus; VP, ventral pallidum; Mid, midbrain; SNR, substantia nigra pars reticulata; PO, pons; 
MO, medulla oblongata; EP, entopedoncular nucleus; VMH, ventromedial hypothalamus; DH, dorsal horn; DLF,  dorsolateral funiculus. Scale 
bars: 1 mm (A-E), 200 μm (Adapted from KANO et al, 2009). 
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The CB1 mRNA displays a general brain distribution. It was described in major neuronal 
populations in the striatum, thalamus, hypothalamus, cerebellum, and lower brain stem and the protein 
mainly in presynaptic elements (Kano et al., 2009). In the hippocampus, the CB1 mRNA is abundantly 
expressed at high levels in several subsets of interneurons (Kano et al., 2009), neurons that co-express 
Glutamic Acid Decarboxylase 65 and Cholecystokinin (CCK) (Marsicano and Lutz, 1999). There is 
also data showing that CB1 is expressed in CCK-positive basket cells although it could not be detected 
in Parvalbumin-positive basket cells. CB1 receptors are not only present in the inhibitory interneurons 
but also in the excitatory glutamatergic pyramidal neurons (Freund et al., 2003). Evidence confirming 
this point was difficult to obtain since CB1 receptors are expressed in significantly lower levels when 
compared with GABAergic interneurons (Marsicano and Lutz, 1999; Marsicano et al., 2003). CB1 
receptor is not restricted to this neuronal populations and it has been reported, for instance, on 
serotonin-releasing neurons and noradrenergic terminals. 
The hydrophobic properties of the endocannabinoid molecules make them apparently able to 
diffuse freely between plasma membranes and interact on an intracellular level (Di Marzo et al., 2004). 
Mitochondria play a central role in the energy production in eukaryotic cells. They synthetize 
Adenosine-5'-triphosphate (ATP) from the breakdown of carbohydrates and fatty acids through a 
process called oxidative phosphorylation. They also play a key role in programmed cell death through 
the intrinsic apoptotic pathway (Lodish et al., 2000). In 2010, Whyte et al., under the previous 
hypothesis that cannabinoids could disturb mitochondrial function, tested mitochondrial O2 
consumption in human oral cancer cells (Tu 183). They found that Δ9-THC or Δ8-THC are potent 
inhibitors of Tu 183 cellular respiration and thereby highly toxic. In 2012, Bénard and colleagues 
showed the localization of CB1 receptors in the mitochondrial membrane from mice hippocampal 
neurons. They also demonstrate that it can control directly cellular respiration and energy production. 
These mitochondrial receptors (mtCB1) also display decreased activity in the complex 1 enzymatic 
activity, in PKA activity and in the levels of cAMP. Moreover, the striking feature is their capacity to 
contribute for endocannabinoid-dependent depolarization-induced suppression of inhibition in the 
hippocampus (Bénard et al., 2012). 
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Part I | Section 2 - Endocannabinoid molecules – Synthesis, Transport 
and Degradation 
 
The discovery of the cannabinoid receptors was followed by the discovery of their endogenous 
agonists: the endocannabinoids. Inside this group of endogenous molecules that bind specifically to the 
cannabinoid receptors, those who are better characterized as specific ligands for the CB1 and CB2 are 
Anandamide and 2-AG (figure 4). These two molecules are structurally based on the Arachidonic Acid 
as well as other long chain polyunsaturated acids.  
Anandamide (from the Sanskrit word ‘ananda’ meaning ‘bliss’) (Di Marzo et al., 1998) was 
first suggested as a natural ligand for the CB1 by Devane et al. (1992) after observing that it was able 
to inhibit the specific binding of a radiolabeled cannabinoid probe in synaptosomal membranes, acting 
as a competitive ligand and inducing psychotropic effect of the cannabinoids. This endogenous 
molecule acts as a partial agonist of both CB1 and CB2 receptors (Onaivi et al., 2005). 
The discovery of a second endocannabinoid molecule came from the fact the, although AEA 
was specific to the receptor, its presence in the brain was very low. 2-AG, an Arachidonic-acid-
containing Monoacylglycerol, was first described by Sugiura et al. (1995). After several binding essays 
they postulated that this molecule could act as an endogenous ligand for endocannabinoid system in 
the brain. In 1997, Stella et al. reported that a cannabinoid ligand isolated from intestinal tissue which 
levels were about 170-fold greater than AEA in brain. They also reported the biosynthesis of 2 AG in 
hippocampal slices after the stimulation of Schaffer Collaterals fibers. Altogether, these results lead 
them to propose 2-AG as the second endogenous cannabinoid ligand in the CNS, also suggesting 2-AG 
could as the main effector of the CB1-mediated regulation in central synapses (Hashimotodani et al., 
2007; Tanimura et al., 2010).  
The role of Astroglial Type 1 Cannabinoid Receptor in Memory Functions 
22 
José Fernando Oliveira da Cruz – Universidade de Coimbra (2013) 
Although Anandamide and 2-AG are the most well-known endocannabinoids, other molecules with 
physiological effects have been described as putative cannabinoid receptor agonists (Figure 4): 1) O-
arachidonoyl-ethanolamine (OAE, Virodhamine); 2) 2-Arachidonyl glyceryl ether (Noladin Ether) and 
3) N-arachidonoyl-dopamine. The first one acts as a selective agonist for CB1, the second as a partial 
agonist for CB2 and CB1 antagonist and the third as a selective agonist for CB 1 and as a potent 
agonist for TRPV1 (Huang et al., 2002). 
 
Due to the lipophilic nature of endocannabinoids and the apparent incapacity for storage inside 
the aqueous medium of synaptic vesicles, the process of synthesis is likely to happen “on demand” 
through a tightly regulated mechanism (Mechoulam et al., 1998). In 1994, Di Marzo et al., reported 
that Anandamide could be produced and released in a calcium dependent way after stimulation with 
membrane-depolarizing agents demonstrating that this molecule could, indeed, be produced “on 
demand”. The initiation of this complex process in hippocampus seems to be potentiated by the 
activation of postsynaptic type 1 glutamate metabotropic receptors and by muscarinic acetylcholine 
receptors (Varma et al., 2001; Kim et al., 2002). 
FIGURE 4 – CHEMICAL STRUCTURES OF ESTABLISHED AND PROPOSED ENDOCANNABINOIDS (Adapted 
from De Petrocellis et al., et al). 
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 The biosynthesis of these two major endocannabinoid molecules involves several hydrolytic 
enzymes that regulate and process the synthesis/degradation of these compounds. Anandamide is 
produced from the precursor N-arachidonoyl Phosphatidylethanolamine (NArPE). This compound is 
synthetized by the enzyme N-Acetyltransferase (NAT) from Glycerophospholipids and 
Phosphatidylethanolamine. NArPE will then be directly converted into Anandamide by the enzyme N-
Acylphosphatidylethanolamine-specific phospholipase D (NAPE- PLD). 2-AG is synthetized from the 
precursor sn-1-acyl-2-arachidonoylglycerol. These precursors can be produced either from the 
hydrolysis of Phosphatidic acid (PA) by the PA phosphohydrolase or from phosphoinositides (PI) after 
catalyzation by a PI-selective phospholipase C (PLC) (De Petrocellis et al., 2004). This AArG will be 
converted into 2-AG by the enzyme sn-1-diacylglycerol lipase (DAGL) (Di Marzo et al., 2004; Di 
Marzo, 2008). Although it is only shown here one pathway for each endocannabinoid, there are several 
new addictions that include new pathways, new enzymes and new intermediate molecules (Further 
reviewed in Di Marzo et al., 2004; De Petrocellis et al., 2004; Di Marzo, 2008). 
After the cellular uptake, the degradations pathway is processed mainly by hydrolytic enzymes. 
Fatty Acid Amide Hydrolase (FAAH) is able to catalyze the conversion of Anandamide with the 
production of Arachidonic Acid and Ethanolamine. Another very important enzyme is the 
Monoacylglycerol Lipase (MAGL). This enzyme is able degrade 2-AG into Arachidonic acid and 
glycerol.  Recombinant FAAH was also shown to be able not only to hydrolyze 2-AG in a much 
efficient way than Anandamide but also Oleamide and Methyl Arachidonate (Goparaju et al., 1998). 
Although the effectiveness of FAAH on degradation of 2-AG, it has been shown by Blankman et al., 
(2007) that the main enzyme responsible for its degradation is MAGL. The correct endocannabinoid 
degradation is very important for the optimal endocannabinoid signaling at glutamate synapses 
(Schlosburg et al. 2010). The whole synthesis, transport and degradation process is summarized in 
figure 5. 
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The degradation/inactivation pathways of these molecules must be very efficient and tightly 
regulate. With classical neurotransmitter molecules (such as glutamate or GABA), the inactivation 
after action can be done by uptake (for further degradation) from synapse by glial cells (such as 
astrocytes) or by neurons. The major question that remains is how are endocannabinoids transported 
through the intracellular or extracellular aqueous media? In 2011, Fu et al., reported that a Fatty Acid 
Amide Hydrolase -1 enzyme variant (FAAH-1) is able to act a specific transported of AEA in neurons 
and other cells types. Named FLAT by the authors (from FAAH-1–like Anandamide Transporter), this 
enzyme was shown to be able to specifically transport AEA and no other endocannabinoid molecules 
such as 2-AG. This was the first evidence of a possible first-in-class specific transporter of 
Anandamide (Marsicano and Chaouloff, 2012). After these interesting findings, a new question arises 
concerning 2-AG: can it be transported in a similar way? 
FIGURE 5 – MAIN ESTABLISHED MECHANISMS FOR ENDOCANNABINOID SYNTHESIS, TRANSPORT AND 
DEGRADATION IN THE BRAIN (Adapted from Di Marzo et al., 2004). 
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Part I | Section 3 - Endocannabinoid Signaling and Synaptic function 
 
The endocannabinoid system exerts an important regulatory and modulatory function and the 
main mechanism of regulation of synaptic plasticity is through retrograde signaling mechanism acting 
in the presynaptic terminals leading to changes in the whole synapse (Figure 6A). Synaptic plasticity 
can result from active-dependent changes that lead to the adaptation of the synapse and has a major 
importance in the neuronal functions (Further discussed in Part III).  
Molecular changes triggered by the action of neurotransmitters (either changes in quantity or 
efficiency in their action at their receptors) have been demonstrated to be influenced by the 
endocannabinoid system, inducing several forms of synaptic plasticity either short and/or long term 
changes (Gerrow and Triller, 2010; Chevaleyre et al., 2006). As this system is present throughout 
excitatory and inhibitory synapses, interpretations about their specific role are very tricky. 
Furthermore, there is also growing evidence of a mechanism of action through a non-retrograde 
signaling cascade involving other potential receptors that respond to endocannabinoid (such as the 
TRPV1 receptors) leading to a non-classical non-retrograde signaling cascade (Figure 6B).  These 
many connections with other neuromodulatory systems draw to a picture even more complex 
underling the general physiological and behavioral aspects of the endocannabinoid system. 
FIGURE 6 – ENDOCANNABINOID NEURONAL SIGNALING PATHWAYS (adapted from Castillo et al., 2012) 
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Section 3.1 – CB1-mediated intracellular signaling pathway 
 
The cannabinoid receptors are known to be the most abundant G protein coupled receptors in 
the brain (Herkenham et al., 1990; Di Marzo et al., 2004) and it is known that the endocannabinoids 
can be released, probably “on demand”, from the postsynaptic to the presynaptic terminal. When the 
CB1 receptors are activated, they will exert an inhibitory effect through a G protein-dependent 
mechanism coupled to the Adenylate Cyclase that will cause a decrease of cAMP production. This 
decrease of cAMP will lead to a decrease of cAMP-dependent protein kinase phosphorylated pathway, 
the Protein Kinase A.  CB1 will also stimulate the MAPK pathway and it is known that this pathway 
controls the expression of several genes that can lead to long lasting cellular effects (Onaivi et al., 
2005). CB1 is also coupled to the inhibition of N-type and P/Q-type of Voltage Activated Calcium 
Channels (thus decreasing Ca
2+
 levels) and the stimulation of inwardly rectifying potassium channels 
in the presynaptic terminal (Figure 7). Altogether these events will produce a hyperpolarization in the 
presynaptic terminal leading to the suppression of neurotransmitter release (Di Marzo et al., 2004; 
Svízenská et al., 2008).  
Another interesting property regarding CB1 is desensitization. When CB1 is stimulated for a 
persistent period, it may lose its capacity to respond with the same efficacy to subsequent stimulations. 
Observations showed that THC treatment causes both region-specific decreases in CB1 receptors and 
G-protein coupling in the brain leading to a possible mechanism of tolerance development (Daigle et 
al., 2008).  
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Section 3.2 – Endocannabinoids as mediators of short-term synaptic plasticity events 
 
As stated before, one of the main consequences of CB1 action is the suppression of 
neurotransmitter release. After the depolarization in the postsynaptic membrane, a transient 
suppression neurotransmitter release is elicited in the presynaptic membrane. This suppression can 
cause both suppression of inhibition or excitation, depending if it occurs, respectively, on GABAergic 
or Glutamatergic neurons (Wilson and Nicoll, 2002). These two events, Depolarization-induced 
Suppression of Inhibition (DSI) and Depolarization-induced Suppression of Excitation (DSE), are 
characterized by events in the postsynaptic and presynaptic membrane. These events are both 
correlated with influx and increase in the calcium concentrations in the postsynaptic neuron. The first 
evidence that DSI was related with retrograde signaling was reported by Wilson and Nicoll (2001). 
They showed that DSI on hippocampus (where CB1 is expressed mainly in GABA-mediated 
inhibitory interneurons and clusters in the axon terminal) could be blocked by a CB1 antagonist and in 
CB1-KO mice (Wilson and Nicoll, 2001). In the same year, Kreitzer and Regehr (2001) showed that 
postsynaptic release of endocannabinoid molecules, in the cerebellum, can also inhibit the excitatory 
FIGURE 7 – ESTABLISHED INTRACELLULAR MECHANISMS UNDERLYING RETROGRADE ENDOCANNABINOID 
SIGNALING (Adapted from Di Marzo et al. 2004) 
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synaptic response in Purkinje cells. The calcium increase in the postsynaptic terminal can be due the 
opening of voltage-gated calcium channels (Wilson and Nicoll, 2002) and there is evidence that 
calcium chelators, when applied postsynaptically, are able to block DSE and DSI (Pitler and Alger, 
1992; Kreitzer and Regehr, 2001). AG-2 seems to be the principal endocannabinoid required to the 
events concerning the activity-dependent retrograde signaling although the relation between the 
Anandamide and the 2-AG in general effects is debatable (Castillo et al., 2012). In this model for short 
term plasticity, the eCBs released from the postsynaptic terminal, are synthetized possibly after the 
calcium increase via Voltage Gated Calcium Channel (VGCC) that stimulates the Ca
2+
 sensitive 
enzymes. Another possible mechanism is the production of 2-AG via PLCβ after the activation of post 
synaptic type I metabotropic glutamate receptors (I mGluR) through glutamate released from the 
presynaptic terminal (Castillo et al., 2012). The proposed mechanism is a cascade that will converge 
and thus leading to the production of endocannabinoids (Figure 8).  
FIGURE 8 – ILLUSTRATIVE DIAGRAM OF ENDOCANNABINOID INDUCED SHORT TERM SYNAPTIC PLASTICITY 
(Adapted from Chevaleyre et al., 2006) 
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Section 3.3 – Endocannabinoids as mediators of long-term synaptic plasticity 
  
It is known that besides the effects on short term plasticity, the ECS is involved in many 
aspects concerning long term plasticity. It has been shown that the stimulation of the CB1 receptors 
can lead, for instance, to the induction of forms of long term depression (LTD) known as 
endocannabinoid-mediated LTD (eCB-LTD) in brain areas such as the hippocampus, amygdala, 
striatum and neocortex (Chevaleyre et al., 2006). Unlike the short term induced synaptic plasticity, the 
continuous activation the presynaptic CB1 is thought to be crucial to the eCB-LTD (although after the 
induction, this activation is not required to sustain the LTD) (Chevaleyre and Castillo 2003; 
Chevaleyre et al., 2006).  
This novel form of activity-dependent long-term depression at the hippocampal inhibitory 
synapses (known as I-LTD) on CA1 pyramidal cells area is known to be mediated by 
endocannabinoids. The induction of this type of synaptic plasticity shares some common features with 
the molecular mechanisms of the short term effects such as the activation of presynaptic CB1 receptors 
(Chevaleyre et al., 2006). Presynaptically released glutamate activates the type I mGluR coupled to the 
PLCβ and DGLα that allows the production and release of 2-AG. This 2-AG will act homosynaptically 
inhibiting the release of excitatory neurotransmitters and heterosynpatically in an inhibitory terminal 
leading to an Inhibitory LTD. The mechanism underlying the LTD in the excitatory terminals is the 
one previously described before and the mechanism underlying the effect in inhibitory terminals is 
basically the same although involving also Calcineurin (CaN). There is a putative involvement of an 
unidentified T target, a RIM1 protein and Rab3B that is also necessary for this inhibitory form of LTD 
(Castillo et al., 2012) (Figure 9). 
The broadly distribution and increasing evidence of the regulation of synaptic plasticity 
indicates a possible correlation between the ECS and complex forms of behavior such as stress and 
depression, memory and learning, regulation of the energy metabolism, sexual behaviors (Pagotto, 
2005; Cota et al., 2006; Hill et al., 2010). 
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Section 3.4 – Knock-out mice models to study CB1 physiology 
 
 Studies in the physiology of the biological systems are based mainly in pharmacological 
approaches using natural and synthetic compounds (agonists, antagonists and inverse agonists) and 
null CB1 mutant lines which are characterized by a complete deletion of the CB1 in the whole 
specimen. Pharmacological approaches, despite of its advantages, display overall limitation such as the 
lack of specificity, drug delivery problems and spatial target inaccuracy (Picciotto and Wickman, 
1998). Because CB1 have an inhibitory effect over the release of glutamate and GABA and the 
expression in GABAergic neurons is much higher than in the Glutamatergic neurons (Kano et al., 
2009), the phenotypes obtained from a pharmacological approach are mainly attributed to direct 
regulation of GABAergic neurotransmission masking other possible mechanisms. In the other hand, a 
general full genetic deletion can also generate a compensation phenomenon in which the body is able 
to re-adapt itself throughout it development to compensate in some extent the unavailability of the 
deleted protein (Picciotto and Wickman, 1998). 
This general compensation of a full deletion can be minimized by restricting CB1 to specific 
cell types. A way to assess specific function of a specific localization of the CB1 is through the 
creation of cell-type specific knockouts through the Cre/LoxP System.  
FIGURE 9 – MOLECULAR MECHANISMS UNDERLYING ENDOCANNABINOID MEDIATED LONG TERM 
SYNAPTIC PLASTICITY (Adapted from Castillo et al., 2012) 
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 The Cre recombinase system is a genetic approached that allows the excision or inversion of 
loxP-flaked Deoxyribonucleic Acid (DNA) segments and the creation of an intermolecular 
recombination between different DNA molecules (Nagy, 2000). The Cre recombinase is a 38kD 
protein that catalyzes a recombination between two of its recognition sites: the loxP sites. These sites 
are a 34 bp consensus sequence which orientation is defined by the asymmetric core sequence (Nagy, 
2000). Since this sequence flanks only the region of interest and does not alter normal gene expression, 
the transgenic mice originated with the flanked gene are considered as wild type mice. To conceive a 
transgenic mouse line with the required knockout target, the mouse containing the floxed gene must be 
crossed with another mouse line expressing Cre Recombinase under the control of a cell type specific 
promoter. The Cre enzyme will then act between the spacer areas of the loxP sites creating the new 
specific transgenic lines without the flanked gene (Nagy, 2000).  
In the endocannabinoid system, in order to create a cell type-specific CB1-KO, the first step is 
the creation of a transgenic line in which the gene of interest (i.e. the CB1 gene) is flanked by a loxP 
sequence. Subsequently these lines will be crossed with another transgenic line expressing Cre 
recombinase under the control of a specific promoter to a particular cell type (Figure 10).  There are 
several knockout mice lines created with this procedure. For instance, in 2003, Marsicano and 
colleagues obtained the (Ca
2+
/calmodulin-dependent protein kinase) CaMKIIα-CB1-KO mice from a 
CB1-floxed (Marsicano et al., 2002) and the CaMKIIα-Cre mice (Casanova et al., 2001). This 
promoter allowed the Cre recombinase expression and consequent excision of the CB1 receptor in the 
principal forebrain neurons. 
FIGURE 10 – CONDITIONAL DELETION OF CB1 GENE THROUGH CRE/LOXP SYSTEM (Adapted from 
Metna-Laurent, 2012) 
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Although targeting specific neuronal cells is quite easy, the same does not occurs when it 
comes to astrocytes. As the most widely used astrocyte specific promoter, Glial Fibrillary Acidic Protein 
(GFAP), is also active in embryonic radial glial that have neurogenic potential, when a conditional 
knockout beginning in embryogenic state using Cre Recombinase is attempted, gene deletion occurs 
also in neurons thereby creating an ambiguous and insufficient transgenic model (Hirrlinger et al., 
2006). 
In 2006, Petra Hirrlinger and colleges, from Frank Kirchhoff lab, developed a method in which 
a different Cre Recombinase system was used: the Tamoxifen-inducible Cre/loxP system (Figure 11). 
They generated a transgenic mutant mice line in which the Cre Recombinase protein was coupled to a 
mutated ligand binding domain of the estrogen receptor: the CreERT2. In this system, the activation of 
the Cre protein is achieved with i.p. injection of Tamoxifen (a selective estrogen response modifier). 
This leads to the complete deletion of the protein of interest reliably in all brain regions allowing the 
functional study of glial proteins in postnatal and adult brain (Hirrlinger et al., 2006). 
 
 
In 2012 and using the same the Tamoxifen-inducible Cre/loxP system described above, Han et 
al., generated a conditional mouse line in which they induced the deletion of the CB1 receptor in 
astrocytes. This mouse line, referred as GFAP.CB1.KO, expresses CreERT2 under the GFAP 
FIGURE 11 – SCHEMATIC REPRESENTATION OF TAMOXIFEN-INDUCIBLE CRE/LOXP SYSTEM (Adapted 
from Hirrlinger et al., 2006). 
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promoter allowing its expression only in astrocytes. Three weeks after the injection of Tamoxifen, the 
line shows complete recombination and deletion of the astrocytic CB1 further confirmed by electron 
microscopy (figure 12) (Han et al., 2012). 
 
 
 
 
 
 
 
 
FIGURE 12 - AN ELECTRON MICROSCOPIC IMAGE SHOWING THE ABSENCE OF CB1 RECEPTOR IN 
ASTROCYTES AND AXONS. CB1 in axons and terminals (small arrows), CB1 in astrocytes (large arrow). The 
scale bars represent 500 nm (Han et al., 2012) 
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Part II – Astrocytes and the Endocannabinoid System  
 
From the Greek glia (meaning glue), glial cells are generally smaller in length than neurons, 
possess multiple complex processes that emerge from their cell bodies, lack axons and dendrites, are 
established in complex networks and do not exhibit electrical properties (Purves et al., 2001;  Giaume 
et al., 2010). Among the known glial cells, the best described are the oligodendroglia, microglia and 
astroglia (Araque and Navarrete, 2010).  
All glial cells have complex and important functions such as the role of oligodendrocytes in the 
myelination of axons and the role of microglia in mechanism of brain defense and debris removal 
(Volterra and Meldolesi, 2005). The more dubious player in this concept of glial cell is the astroglia. 
For a long time astroglia was thought to act just on a supportive way contrasting a recent model in 
which it is believed that it participates in more complex processes such as neurotransmission and 
neuromodulation, development, maintenance and recovery of synapses (Auld and Robitaille, 2003).  
From just supporting functions, new perspectives arrive concerning astrocytes and the control 
of synapse establishment and function, adult neurogenesis and brain vascular tone (Volterra and 
Meldolesi, 2005). In truth, they are vital for the survival and the correct function of the brain (Eroglu 
and Barres, 2010; Zangh and Barres, 2010). 
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Part II | Section 1 – Biology of Astrocytes   
 
Section 1.0 – General Description, Functions and Properties 
 
The Astrocytes derive from the same neural stem cells that give origin to oligodendrocytes 
although differently from the microglia which are originated from the immune system lineages (Eroglu 
and Barres, 2010). Astrocytes development tends to occur after the beginning of neuron development. 
Still, early they start to participate in striking functions in brain development such as guiding the 
migration of axons and certain neuroblasts (Sofroniew and Vinters, 2010).  They participate in the 
correct foundation of the CNS being a key piece in the general process of differentiation. 
 
According to morphological and anatomical locations, in rodents, they can be divided in two 
main classes: the protoplasmatic astrocytes and the fibrous astrocytes. The protoplasmatic astrocytes, 
which can be found in all gray matter, are highly ramified, contact with blood vessels and are capable 
B 
FIGURE 13 – ASTROCYTES. (A) Representation of a neuron and an astrocyte stained with the Golgi method 
from rat hippocampus. The astrocyte cell body is focused in the small bottom right square. (B) Protoplasmatic 
astrocyte from the hippocampus CA1 stratum radiatum. (C) 3D Representation of an astrocytic process (Blue) 
interacting with several synapses (red, yellow and violet) (A and C, adapted from Perea et al., 2009; B adapted 
from Bushong et al., 2002). 
B     
C     
A 
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of ensheathing synapses (Eroglu and Barres, 2010). The second class can be found mainly in all white 
matter and contact mainly with Ranvier nodes of axons (Eroglu and Barres, 2010). This division may 
not be adequate to separate the different astrocytes classes because they possess many different 
populations and they display distinct properties in different brain areas. It is also known that astrocytes 
are different among species, for instance, it is known that the human brain contains a higher diversity 
of astrocytes populations, more ramified and bigger that rodents (Eroglu and Barres, 2010). In 2009, 
Oberheim and her colleagues describe that, for example, human cortical astrocytes are both larger nd 
structurally both more complex and more diverse than those of rodents. Nevertheless this model of 
description still maintains its validity (Figure 13) (Sofroniew and Vinters, 2010).  
The astrocytes retain in their structure an intermediate filament protein which is commonly 
used as a marker for astrocytes, the Glial Fibrillary Acid Protein (GFAP). This protein is  more 
expressed upon brain damage or during CNS degeneration and is known to be highly expressed in the 
aged brain (Middeldorp and Hol, 2011).  It is very important for cell support since it can maintain the 
cytoskeleton structure and it is associated with the transduction of molecular signals within these cells. 
Studies about this protein showed it importance in the processes of reactive astrogliosis and glial scar 
formation yet not for the normal function of the cell. Evidence obtained from double staining of 
astrocytes showed that some healthy astrocytes do not produce detectable molecule and it is also 
important to notice that GFAP is not present across all cell body but only in main stem branches 
(Figure 13) (Sofroniew and Vinters, 2010). Thereby, this cell marker is mainly used just to distinguish 
visually and genetically neurons from astrocytes (Middeldorp and Hol, 2011). Other proteins like the 
intermediate filament Vimentin, calcium binding protein beta (S100β) or  the  astroglial  glutamate  
transporters  EAAT1/GLAST  and  EAAT2/GTL-1 can be targeted specifically yet it is important to 
FIGURE 12 - GFAP IMMUNOLABELING OF LUCIFER YELLOW-FILLED ASTROCYTES OF CA1 STRATUM 
RADIATUM FROM RAT HIPPOCAMPUS A) Astrocytes labeled with LY display in their structure GFAP in their 
skeleton. B) Demonstrates the limited extent of GFAP throughout individual astrocytes which seems to be 
restricted to main branches not covering all the astrocyte’s surface (Adapted from Bushong et al., 2002)   
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state that they are region-specific and do not permit enough astrocytic delimitation required for 
effective co-localization studies  (Middeldorp and Hol, 2011). It is important to make clear that so far, 
no exclusive marker has been identified in mature astrocytes (McGann et al., 2012). 
The astrocytes are known to take part in several functions that are essential to the correct 
physiology of the brain. They affect directly brain metabolism, neurotransmitter uptake, 
neuroinflammation, neurogenesis and more recently and less accepted, direct influence over synaptic 
plasticity (Figure 15). The evidence of the major importance of the astrocytes starts in the developing 
CNS. It is known that astrocytes are able to take a part in guiding neuritis thanks to their derived 
guidance molecules (Powell and Geller, 1999). They are also suggested to be essential to the formation 
of functional synapses through the release of molecular signals such as thrombospondin 
(Christopherson et al., 2005). They can also control fluid volume in the extracellular space, the 
regulation of ion concentrations and the uptake of neurotransmitter that are released during neuronal 
activity. Focusing on the regulation of the fluid levels, when for some reason there is an edema (due to 
pathological conditions). This control on fluid levels, ion, pH, and transmitter homeostasis (Sofroniew 
and Vinters, 2010) is important to the maintenance of correct synapse function. Potassium, due to its 
important effect over the neuronal membrane potential, must be under tight regulation because 
impairments on the concentration can lead to hyperexitability with pathological consequences.  
Neurotransmitter uptake and homeostasis are also important to maintain a correct functional 
synaptic activity. Astrocytes express in their membranes transporters that are able to uptake, for 
example, glutamate. The excess of stimulation due to high concentrations of glutamate is also known 
to cause excitotoxicity (Purves et al., 2001) with severe consequences to neuron viability (On example 
is the glutamate spillover that it’s associated with epileptic crisis). This regulation exhibits the indirect 
involvement of the astrocyte in the correct functioning the synapses (Haydon and Halassa, 2010). CB1 
has been shown to protect against the excitotoxicity (Marsicano et al., 2003) and more recently, in 
2010, Loría and colleagues showed that endocannabinoid tone leads to neuroprotection against (±)-α-
Amino-3-hydroxy-5-methylisoxazole-4-propionic acid hydrate receptor (AMPAR)-induced 
excitotoxicity (Loría et al., 2010). 
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Astrocytes are also known to contact and ensheathe directly blood vessels, controlling the 
molecules that diffuse into the brain through a close association named blood brain barrier (BBB). The 
BBB is formed by endothelial cells, perivascular pericytes and by the astrocytes. Astrocytes can also 
release molecules such as prostaglandins and nitric oxide that underlie the regulation of the blood flow, 
thus controlling the amount of blood that can transverse the brain during a certain event.  
  
Another function that is attributed to the astrocytes is their role in the regulation of brain 
inflammation induced by several insults such as infections (Sofroniew and Vinters, 2010). Astrocytes, 
when activated, are able to release immune mediators that can stimulate both neuroprotective and 
neurotoxic effects in a process called reactive astrogliosis (Sofroniew and Vinters, 2010). This 
complex phenomenon, which is a pathological land mark to scan disease in the CNS, does not have a 
concrete definition.  Sofroniew and Vinters (2010), describe reactive astrogliosis in four categories that 
include: physiological changes of astrocytes in response to perturbations and injuries against the CNS; 
FIGURE 15 – GLOBAL, ESTABLISHED AND PUTATIVE, FUNCTIONS OF ASTROCYTES IN BRAIN 
PHYSIOLOGY. (Adapted from Sofroniew and Vinters, 2010) 
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these changes vary with the degree of the insult with progressive alterations in molecular and structural 
properties (including proliferation and scar formation), the events are context-specific and can be seen 
in variations of inter- and intracellular signaling molecules; molecular changes during this process can 
lead to loss or gain in astrocytic functions that can affect both positively and negatively the 
connections with surrounding neuronal cohorts (Sofroniew and Vinters, 2010). The endocannabinoid 
system has been shown to inhibit the release of inflammatory cytokines from reactive astrocytes, 
thereby exerting anti-inflammatory properties. 
Astrocytes are also coupled to metabolic functions. It is known that the brain, although only 
representing 2% of the body weight, can consume about 20% of the body total energy. The astrocyte’s 
processes involve tightly the blood vessels making them a platform to retrieve glucose from the blood 
vessels to supply neurons with brain metabolites. Astrocytes possess an energy reserve of glycogen 
that can be used to maintain neuronal activity even in times of hypoglycemia or high brain activity 
(Sofroniew and Vinters, 2010). Another important subtract is lactate. Lactate has been shown to be 
used by neurons as a principal energy subtract (Bouzier-Sore et al., 2003) and it was also shown that 
astrocyte-neuron lactate transport shuttle is required for long-term memory formation (Suzuki et al., 
2011). Neurons can also use energy from fatty acids when they are the unique available source of 
energy (Figure 15) (Sofroniew and Vinters, 2010).  
The astrocytes exist in a close relation with neurons and also among themselves. They are 
established in networks and they are able to communicate among themselves through gap junctions 
(Figure 16A and C). These gap junctions, which are composed by connexins, form channels in the 
plasma membrane that allow the traffic of molecules between astrocytes (Giaume et al., 2010). 
Astrocytes can be found associated with neurons, other astrocytes and the vascular system (Paixão and 
Klein, 2010). This new concept of astrocytic communication reveals important insights when 
comparing with the general picture of the system. The astrocytes are able to exhibit in vitro (Navarrete 
et al., 2013) (figure 16B) and in vivo calcium excitability (Kuga et al., 2011). This property was shown 
to be correlated with neuronal activity in awake behaving mice (Paixão and Klein, 2010). In 2009, 
Nimmerjahn his colleagues, described in awake and behaving mice that Bergmann glial cells could 
exhibit forms of calcium excitation. In one of the experiments, during locomotor activity, calcium 
excitation was observed in networks of hundreds of Bergmann glial cells extending across several 
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hundred micrometers. This excitability promoted by specific behavior could even lead to changes in 
brain dynamics and blood flow (Nimmerjahn et al., 2009). 
FIGURE 16 – ASTROCYTIC NETWORK PROPERTIES. A) Astrocytes communicate among themselves through 
gap junctions and hemi channels. Each one is responsible for its own domain of influence that is not overlapped by 
neighbor astrocytes. B) When stimulated with ATP, human hippocampal astrocytes  exhibit increase in intracellular 
Calcium concentrations that can travel throughout the network (Navarrete et al., 2013). C) Astrocytes (in light 
blue) can sustain neuronal activity through the networks. In the presence of neuronal activity, an  intercellular route 
(dark blue) is established to allow that trafficking of metabolic subtracts from blood vessels directly to areas of 
high synaptic activity (red arrows) (Giaume et al., 2010). (A, C adapted from Giaume et al., 2010; B adapted from 
Navarrete et al., 2013) 
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Part II | Section 2 – Astrocytes and Synaptic Plasticity   
 
 
Section 2.1 – Neuronal-glial signaling: the tripartite synapse 
 
Astrocytes were proposed as cellular processors of synaptic information in a concept called the 
tripartite synapse (Figure 17). This concept, originated in 1999 by Araque and colleagues, is based on 
evidence supporting bidirectional communication between astrocytes and neurons. Astrocytes are 
capable to display cellular ion excitability (through the intracellular calcium waves), show specificity 
in the response to specific synaptic inputs (Perea et al., 2009), display nonlinear input-output 
relationships and show cell intrinsic properties (for instance, the calcium signal is not non linearly 
modulated by simultaneously exogenous application of different neurotransmitters) (Perea and Araque, 
2009).  
FIGURE 17 – TRIPARTITE SYNAPSE. (A) The Electron microscopy image shows an astrocytic process that 
ensheathes a synaptic terminal. (B) In a simple view, neurotransmitters released from the pre synaptic terminal, 
besides the action on the postsynaptic terminal, can act on the astrocytic process mediating the release of 
gliotransmitters through a putative calcium mediated mechanism (Perea et al., 2009). This release of gliotransmitters 
can affect the presynaptic terminal and/or the post synaptic terminal (C). Astrocytes can also receive an input or 
send an output to/from a neighbor astrocyte bellowing to the astrocytic network. Post synaptic density (psd); Spine 
(sp); Astrocyte (astro); Axon (ax); Gliotransmitters (Gt); Neurotransmitters (Nt); Pre synaptic terminal (Pre); 
Postsynaptic terminal (Post); Input (In); Output (Out)   (A and B Adapted from Perea et al., 2009; C adapted from 
DePittà et al., 2012). 
B 
C 
A 
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The astrocytes networks were proposed to coordinate the activity of local groups of synapses 
through, for example, the release of gliotransmitters that can affect directly neuronal activity (Giaume 
et al., 2010) and there is evidence showing that astrocytes can release, among molecules: Glutamate, 
D-serine, ATP, Adenosine and Tumor necrosis factor-alpha (TNF-α), among others (Paixão and Klein, 
2010). For example, it has been shown that following tetanic stimulation of CA1 afferents, astrocytes 
can release ATP that can be converted into adenosine, acting this way on the presynaptic membrane 
adenosine receptor A1 which will exerted its effects by depressing the excitatory transmission. This 
active interaction can lead to the regulation of synaptic transmission with important consequences to 
processing, transfer and storage of information by the central nervous system (Perea et al, 2009).  
The mechanisms and the role of gliotransmission are still not clear. Mechanisms proposed for 
gliotransmission may include: calcium-dependent vesicle exocytosis, through amino acid transporters, 
connexin/pannexin hemi channels, pore-forming P2X7 receptors and the swelling-induced activation 
of volume anion channels (Perea et al., 2009) (Figure 17B). Recently, concerning glutamate, an 
interesting mechanism of glutamate release through GPCR was described. This mechanism proposes 
the glutamate release through: 1) a fast way through activation of Gαi, dissociation of Gβγ, and 
subsequent opening of glutamate-permeable, by the two-pore domain potassium channel TREK-1 and 
2) a slow way by calcium dependent mechanism that requires the Gαq activation and opening of 
glutamate-permeable, Ca2+- activated anion channel Best1 (Woo et al., 2012). Another example in 
which astrocytes can influence synaptic plasticity events is through the release of D-Serine. This 
amino acid, which is an enantiomer of L-Serine, is present in high levels in brain and among other 
areas, in the hippocampus. D-Serine, which is a N-methyl-D-aspartate-type glutamate receptor 
(NMDAR) co-agonist, is able to bind to the glycine binding site and thereby regulate NMDAR 
transmission during synaptic plasticity events. Several pieces of data show that D-Serine is 
predominantly localized in astrocytes (Schell et al., 1995) and it can be released through a calcium 
dependent mechanism (Henneberger et a., 2010). Nevertheless it has been described that D-Serine can 
also be released from neurons (Kartvelishvily et al., 2006; Ehmsen et al., 2013). In vitro 
electrophysiological approach showed that D-Serine can be released from astrocytes in calcium-
depend way and a single astrocyte can control NMDAR-dependent plasticity in many thousands of 
excitatory synapses from its own non overlapping domain (Henneberger et al., 2010).  
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Another molecule released from astrocytes that have been shown to be important for synaptic 
plasticity is the lactate.  In 2011, Suzuki and colleagues reported that, in the rat hippocampus, lactate 
derived from glycogen and consequent released by astrocytes is essential for long term memory 
formation and maintenance of long-term potentiation in vivo. In this study they showed that by 
disrupting the expression of the astrocytic lactate transporters Mono Carboxylate Transporter (MCT4) 
or MCT1 is possible to cause amnesia as well as LTP impairments that can be rescued by L-Lactate 
and not by glucose. The disruption of the neuronal MCT2 leads also to amnesia that cannot be reverse 
by the administration of L-lactate or glucose. The lactate importation through MCT2 is important and 
necessary for the expression of Arc and for the phosphorylation of (cAMP response element-binding 
protein) CREB and cofilin (Bezzi and Volterra, 2011). Altogether these events make this “astrocyte-
neuron lactate shuttle” required for gene expression, protein synthesis, and formation of new synaptic 
connections that underlies long term memory formation (Bezzi and Volterra, 2011; Suzuki et al., 
2011).  
Nevertheless, the mechanisms that underlie gliotransmission remain largely unclear mostly due 
to the techniques that do not allow enough precision and specificity to identify correctly glial 
components. 
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Part II | Section 3 – Astrocytes and the CB1 receptors 
  
Section 3.1 – CB1 receptor is present in astrocytes 
 
 
The presence of the CB1 on this type of glial cells started with evidence showing that mRNA 
from CB1 is present in primary cultures of rat astrocytes (Bouaboula et al., 1995). Since those results, 
successive attempts were tried to give clear evidence of the presence of the protein in these cells, not 
only in primary cultures but also in vivo models. It is known that astrocytes in primary cultures do not 
develop a normal structural and anatomical shape when comparing with the ones found in vivo. The 
simple fact can interfere with a correct way to evaluate the presence of these receptors in these cell 
types (Verkhatsky et al., 2011). The evidence of functional the astroglial CB1 control in bidirectional 
interactions between neurons and astrocytes came with functional studies from Navarrete and Araque 
(2008, 2010). Nevertheless it was in 2012, with Han et al., (2012) that the first conclusive in vivo 
evidence of this receptor was presented. In this study the authors generated a conditional mutant in 
which they delete specifically CB1 on astrocytes (described in Part I, Section 3.4 and further discussed 
in Part II, Section 3.2).  
  
Section 3.2 – Astroglial CB1 and the Tripartite Synapse  
  
Although there is evidence showing that astrocytes can express CB1 on their membrane in vivo (Han et 
al., 2012) and that they exhibit the machinery necessary to produce 2-AG and Anandamide in culture (Stella, 
2009), it is not clear their influence in synaptic plasticity events. 
Functional evidence of Astroglial CB1 involvement in endocannabinoid-mediated communication 
between neurons and glia in synaptic function came from two important studies. The first, from Navarrete and 
Araque (2008), shows that postsynaptic production of endocannabinoids by hippocampal CA1 pyramidal 
neurons can act on a putative cannabinoid receptors in astrocytes coupled to Gq/11 that is coupled to the 
phospholipase C, leading to an increase of intracellular calcium levels. This calcium increase is thought to 
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underlie glutamate release to the synapse and consequent activation of NMDAR transmission (Navarrete and 
Araque, 2008). Later on in 2010, by the same group of Araque, It was shown that Glutamate release through the 
same mechanism described earlier is able to act on presynaptic glutamate metabotropic receptors (mGuR1) 
leading to the potentiation of synaptic transmission and to a short-term facilitation of the neurotransmitter 
release (Navarrete and Araque, 2010). Altogether, the mechanism of eCB action on short term plasticity would 
be through the Depolarization Suppression of Neurotransmitter release through presynaptic CB1 receptors and 
to indirect facilitate the neurotransmitter release through astroglial CB1 (Figure 18A) (Castillo et al., 2012). 
 
Endocannabinoids have been also implied in mechanisms of long term synaptic plasticity. The repetitive 
pairings of post-before-presynaptic activity is able to induce Spike timing-dependent LTD (tLTD) between 
neocortical pyramidal neurons (Figure 18B). The neuronal endocannabinoids produced under the repetitive 
pairings will act on the astrocytic CB1, triggering glutamate release that will act on the presynaptic NMDAR 
leading to a depression on neurotransmitters release (Castillo et al., 2012). Another interesting model of long 
term plasticity involving the astroglial CB1 receptor is the in vivo LTD production at CA3-CA1 synapses and 
subsequent working memory impairment following THC administration (Han et al., 2012). In this model, THC 
FIGURE 18 - ASTROGLIAL CB1 MEDIATED SHORT TERM AND LONG TERM SYNAPTIC PLASTICITY. 
(Adapted from Castillo et al., 2012) 
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administration is able to activate astroglial CB1 and the postsynaptic GluN2B-containing NMDAR (possibly by 
the putative release of glutamate from astrocytes following THC binding to the astroglial CB1) that triggers an 
AMPAR endocytosis mediated expression of in vivo LTD at CA3-CA1 synapses. Furthermore the authors 
related the this LTD induced by THC administration with a working memory impairment observed in  
glutamatergic and GABAergic-specific CB1 knockout mice but not in astroglial CB1 knockout mice (Figure 
19). Still, the endogenous role of endocannabinoid signaling remains highly unclear. 
FIGURE 19 – PROPOSED IN VIVO LTD PRODUCTION AT CA3-CA1 SCHAFFER COLLATERAL SYNAPSES 
FOLLOWING THC ADMINISTRATION (From Han et al., 2012). 
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Part III – CB1 Receptors and memory  
 
 
Part III | Section 1 – Memory Systems 
 
 
Memory was once described by Milner and colleagues (1998) as ability the by which 
individuals were able to retain and recall past experiences based on the processes of learning, retention 
and retrieval. This complex ability requires disparate brain regions thereby originating different 
partially independent memory systems that can operate in parallel (Henke, 2010). This allows the 
survival, adaptation, well-being and adaptation of complex organisms (Tronson and Taylor, 2007).  
Studies performed on patients shows that some of them are accessible to consciousness and 
other aren’t. This fact suggested the existence of two different systems of long term memory: 
declarative versus non-declarative memory (Figure 20) (Henke, 2010). The declarative memory 
referred above can be characterized by the recollection of memories such as autobiographical events 
(episodic memory) or even general knowledge (semantic memory). On the other hand, the non-
declarative memory consists in procedural learning of sensorimotor and cognitive skills such as tying a 
shoe or reading (Squire, 2009).  
The memory formation and the brain areas involved are still in great debate. Concerning 
declarative memory system, the medial temporal lobe is the group that has been shown to be primarily 
responsible for this function (Squire and Zola-Morgan, 1991). This area is composed by the 
hippocampal complex (CA fields, the dentate gyrus and the subicular complex) together with the 
adjacent entorhinal, perihinal and parahippocampal cortices and are responsible for essential 
phenomena involving memory formation and consolidation after a learning period (Squire, 2009). 
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The formation of memory in traditional view starts with the event (Figure 21). This event will 
be encoded and the memory starts to be established. During this encoding, immediately a new phase 
starts: the consolidation. In this phase the memory becomes permanent and stored (Nadel et al., 2012). 
In the traditional view of memory formation, once a memory is permanent no changes can occur in its 
form.  
However recently, a new theory challenges this very concept of memory formation. The 
concept of reconsolidation, shown in figure 22, supports the fact that when a memory suffers retrieval, 
FIGURE 20 – DECLARATIVE AND NON-DECLARATIVE SYSTEMS OF LONG TERM MEMORY (From Henke, 
2010). 
FIGURE 21 – TRADITIONAL VIEW OVER THE PROCESS OF MEMORY FORMATION (Adapted from Nadel et 
al., 2012). 
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it became plastic and can be vulnerable to modifications making thereby the final memory not a 
reliable picture of what happened by more like a painting that small by small loses its colorful 
appearance (Squire, 2009). The retrieval process can put the memory in a labile state, making it prone 
to destabilization. For example, through protein synthesis inhibitors (disrupting the memory) or 
through a novel experience that updates the previous memory (Nadel et al., 2012). 
  
 
 Memory functions are incredible diverse and the whole field is too vast to be covered in some 
paragraphs. More concerning to the objective of this introduction, a specific type of declarative 
memory will be introduced. Nevertheless, there are much more mechanism and types of memory that 
are widely covered in literature (for further information on: Tulving, 2002; Wood et al., 2012)  
FIGURE 22 – RECONSOLIDATION OF A FIXED MEMORY. (Adapted from Nadel et al., 2012). 
The role of Astroglial Type 1 Cannabinoid Receptor in Memory Functions 
50 
José Fernando Oliveira da Cruz – Universidade de Coimbra (2013) 
Part III | Section 2 – Molecular Mechanisms Underlying Memory 
 
Understanding how memory is formed and what kind of changes occurs in the brain is quite an 
intensive hot topic in brain research. Evidence provided from lesions in hippocampus and memory 
deficits concerning episodic memory indicate a major role of hippocampus in memory formation and 
storage (Squire et al., 2009). In the past decades, the hippocampus has been extensively studied for 
molecular changes in synaptic composition and many theories were drawn from the acquired data. 
 Synaptic plasticity, which refers to activity dependent changes in the synapse form and 
composition, has been extensively studied in the hippocampus and it is believed to underlie learning 
and memory. These studies aimed to identify molecular mechanisms that could induce changes in the 
synapses. The mechanisms vary from identifying cell biological processes, the synaptic release and 
recycling of neurotransmitters, neurotransmitters receptors trafficking, cell adhesion, stimulus-induced 
changes in gene expression in neurons, among others (Ho et al., 2011). All this processes have the 
power to shape in a long term the synapse in experience directed changes which together forms the 
foundation of the mechanism that are believed to underlie learning and memory. 
 Long term changes in synaptic plasticity can be induced by several and distinct mechanisms. 
Due to the nature of this introduction the one focused is the NMDAR-dependent long term synaptic 
plasticity. 
 
Section 2.1 – NMDAR dependent long term synaptic plasticity 
 
The anatomy of the hippocampus makes this structure suitable for electrophysiological 
approaches that are useful to study mechanisms of synaptic function. There are three main sequential 
pathways and each of them encloses specific cell types and projections. In electrophysiology studies 
either in vivo or in vitro, the stimulation of the axons coming from the CA3 neurons with a specific 
frequency stimulus is able to induce changes in the synapses from the stratum radiatum of CA1 (Figure 
23). This CA3-CA1 pathway is commonly known as Schaffer Collateral Pathway. High frequency 
stimulation is able to induce long term potentiation of the synapses (LTP) and low frequency 
stimulation is able to induce long term depression of the synaptic strength (LTD) both lasting from 
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hours to months (Lamprecht and LeDoux, 2004). It is also known that in CA1 synapses, specific 
stimulation protocols are able to induce and long term potentiation dependent on NMDA receptors (Ho 
et al., 2011). NMDAR have been shown to be important for several types of memory and they are 
important to the induction of long term synaptic plasticity in hippocampal synapses (Nakazawa et al., 
2004).  
This induction of long term changes in synaptic plasticity in excitatory glutamatergic synapses 
starts with the release of the main brain excitatory neurotransmitter: glutamate (Hu et al., 2011). This 
neurotransmitter is release from the presynaptic cell in a rapid and highly regulated vesicular 
exocytosis mechanism  (Figure 24A). These vesicles are readily docked in the active zone of release of 
the presynaptic terminal and when an action potential arrives to this area, the increase of intracellular 
calcium (mainly through VGCC) leads to the fusion of the vesicles with the release of the 
neurotransmitter in the intermediary area called synaptic cleft. When glutamate is release in the cleft, it 
will bind to the AMPAR. These receptors which are important for the expression and maintenance of 
LTP can be activated by binding of glutamate at resting membrane potential allowing the influx of 
calcium. This depolarization of the membrane will allow the activation of NMDAR. NMDAR are 
FIGURE 23 – SCHEMATIC REPRESENTATION OF AN HIPPOCAMPAL TRANSVERSE SLICE. In this 
example is possible to distinguish three well preserved ipsilateral synaptic pathways: Perforant pathway that 
concerns axons from entorhinal cortex that synapse with dendrites of dentate granule cells, Mossy fibers that 
comprises the axons from dentate granule cells that synapse with CA3 pyramidal neuronal dendrites and 
Schaffer Collateral which concerns the axons deriving from CA3 that synapse in CA1 pyramidal neuronal 
dendrites (from Ho et al., 2011). 
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present in the postsynaptic membrane and are constitutively blocked by Mg
2+
. The depolarization 
induced by AMPAR will release the NMDAR from the block allowing the binding of glutamate and co 
agonist which is usually represented as glycine. This binding will allow the activation of the NMDAR 
and will allow the calcium influx to the postsynaptic membrane. The postsynaptic increase of calcium 
concentration will allow the expression of long term changes in the synaptic plasticity where LTP 
requires large calcium influx and LTP low influx. The LTP in CA1 is known to be dependent on the 
activation of Ca2+/Calmodulin-dependent protein kinase (CaMKII). Neuronal activity leads to the 
translocation of this enzyme to the PSD where it can phosphorylate many other postsynaptic density 
(PSD) proteins. The autophosphorylation is believed to be important to the LTP induction and 
maintenance (Hu et al., 2011). These changes can be characterized by morphological alterations 
through cytoskeleton regulation, transcription of RNA in the nucleus through modulation of 
transcription factors, increase of protein synthesis either on the cell body either in the dendrite (Santos 
et al., 2010), neurotransmitter release quantity, increasing in presynaptic vesicles, postsynaptic 
ribosomes and changes in the number and spine’s morphology (Lamprecht and LeDoux, 2004) (Figure 
23B). 
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FIGURE 24 – (A) MOLECULAR MECHANISMS UNDERLYING INITIATION AND MAINTENANCE OF LONG 
TERM POTENTIATION AND (B) MORPHOLOGICAL CHANGES IN SPINES AFTER LTP (Adapted from 
Lamprecht and LeDoux, 2004). 
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Section 2.2 – NMDA Receptors 
 
NMDAR exist in di-heteromeric or tri-heteromeric forms that confer them unique properties 
that are thought to be involved in their localization and function (Cull-Candy et al., 2001). The several 
subunits are: GluN1, GluN2A–D, and GluN3A and B (Figure 25A and B).  
From these seven subunits the one that is indispensable for the correct functioning of the 
NDMAR, being thereby always present in the heteromers, is the subunit GluN1 (Nakazawa et al., 
2004). Inhibition of the GluN1 either by direct inhibition with a specific NMDAR antagonist DL-2-
Amino-5-phosphonovaleric acid (AP-5) or by the selective deletion of GluN1 gene show an inhibition 
on LTP induction in the neurons that lack this protein (Nakazawa et al., 2004). It is known that 
NMDAR can have different functions depending if their expression is synaptic or extrasynaptic. 
Literature currently available indicate that the NMDAR present in the synaptic membrane are able to 
act primarily through nuclear Ca
2+
 signaling, leading to the build-up of a neuroprotective action and 
the stimulation of NMDARs in the extra-synaptic area can promote cell death (Hardingham and 
Bading, 2010). There is evidence indicating the composition of these receptors it’s not the same 
concerning the subunits.  
To the activation of the NMDAR, it is needed cooperation between two molecules: Glycine, a 
co-agonist that binds to residues located in the GluN1 subunits, and glutamate which binds to residues 
located in GluN2 subunits. Not only Glycine is important to the activation of this molecule since D-
serine can also act as co-agonist (further discussed below). Recently, it has been proposed that 
different NMDAR, synaptic and extrasynaptic, are gated by different endogenous co-agonists. In this 
study, from Stephane Oliet’s group, they reported that synaptic and extra synaptic NMDAR are gated 
differentially by D-Serine and Glycine, respectively. There is a regionalization of each of the co 
agonist and this availability can be related with long term synaptic plasticity events. It was shown that 
D-Serine availability in the synapse is essential to the induction of LTP and neurotoxicity effect 
whereas the availability of both D-Serine synaptically and Glycine extrasynaptically is essential for the 
induction of LTD and neuroprotection (Papouin et al., 2012). They also show that NMDAR 
composition present in the synapse is rich in heteromers containing GluN2A subunits and NMDAR 
composition in the extrasynaptic space is rich in Glu2B subunit heteromers (Papouin et al., 2012). 
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Section 2.3 – D-Serine and NMDA transmission 
 
D-Serine is a NMDAR co-agonist acting on the Glycine binding site that is thought to play a 
major role in NMDAR dependent synaptic plasticity. D-Serine is an enantiomer of L-serine converted 
through the action of Serine Racemase. This enzyme, was once thought to be inexistent in organisms 
besides bacteria or insects, was described in the brain in 1999 after a period where it was not clear how 
could D-Serine levels be so high in brain tissues (Wolosker et al., 1999). D-Serine shows particularly 
FIGURE 25 – NMDA RECEPTORS: DIVERSITY, STRUCTURE AND EXPRESSION PATTERN. A) Seven 
subunits of NMDA receptors have been identified: GluN1, GluN2A–D, and GluN3A and B. M1-4 indicate 
membrane segments. B) NMDAR can be found in Di-heteromeric or Tri-heteromeric forms. C) Patterns of 
NMDAR subunit expression in adult mouse brain (Adapted from Paoletti et al., 2013).  
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high levels in the hippocampus (Henneberger et al., 2012), more specifically in secretory vesicles 
inside astrocytes (Schell et al., 1995). 
 
The discovery of D-Serine’s agonist properties of NMDAR triggered questions concerning it 
biological functions. Experimental evidence shows that D-Serine produced by Serine Racemase, stored 
and release by astrocytes is important for the modulation of NMDAR transmission mediated changes 
in synaptic plasticity (Henneberger et al., 2012). One of the experiments that showed the importance of 
D-Serine release by astrocytes was carried out in the hypothalamic nucleus where astrocytic processes 
retract from neurons during the physiological onset of lactation (Henneberger et al., 2012). In this 
study, Panatier and colleagues (2006) showed that during lactation, where this retraction occurred, the 
NMDAR mediated synaptic plasticity decreased and LTP was mainly suppressed. These events where 
fully reversed by D-Serine exogenous administration. These results imply that the astrocytic coverage 
contributes for affecting availability of NMDAR for activation and thus the activity dependence of 
long-term synaptic changes (Panatier et al., 2006). In another interesting work, in 2010, Henneberger 
and colleagues reported a mechanism in which a calcium dependent release of astrocytic D-Serine 
controls NMDAR-dependent plasticity in thousands of excitatory synapses (Henneberger et al., 2010).  
Altogether this results fuel the idea that astrocytes are important for overall synaptic plasticity 
events and that gliotransmission can play an important role in NMDAR mediated long term changes. 
 
FIGURE 26 – MECHANISM OF D-SERINE PRODUCTION. Serine Racemase is able to convert L-Serine into D-
Serine or break down into Pyruvate and Ammonia (From Henneberger et al., 2012). 
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Section 2.4 – Synaptic plasticity and Memory 
 
Long term synaptic changes, such as LTP, are thought to underlie learning and memory. In this 
context the experimental model that could be used to test this hypothesis would be a trial in which the 
inhibition of the long term potentiation, for example, in the hippocampus could impair memory 
without changing other parameters (Neves et al., 2008). One of the possible approaches used is the 
local infusion of a NMDA blocker like AP-5 (2-amino-5-phosphonovaleric acid). In an experiment 
performed by Morris and colleagues in 1986 (Morris et al., 1986) the infusion of this drug is able to 
strongly impair the learning and memory formation in the Morris Water Maze without changing basal 
transmission. Furthermore, in another recently interesting experiment, it has been showed that the 
inhibition of the active form of the Protein kinase M ζ (PKMζ) by ZIP (myristoylated zeta-pseudo 
substrate inhibitory peptide) intra hippocampal infusion is able impair spatial memory and LTP even 
when administered several days after the memory formation (Neves et al., 2008). Nevertheless, it is 
important to have caution when analyzing such striking results. Recently two studies published in the 
beginning of the year 2013 and using genetic deletion of PKMζ, show that ZIP reverses late LTP and 
long-term memory in PKMζ knockout mice maybe through an unspecific PKMζ independent 
mechanism (Lee et al., 2013; Volk et al., 2013). Other approaches focused in the deletion of the GluN1 
subunit of NMDAR in the CA1 subfield of the hippocampus. This subunit is known to be necessary 
for LTP induction and in this KO model mice showed a suppression of both LTP and Spatial Learning. 
Nevertheless it is not possible to correlated an LTP impairment with memory deficits because other 
mechanism dependent on GluN1, such as LTD, are also impaired (Neves et al., 2008).  
Is important to focus on the fact that, based on current literature, it is not possible to direct 
correlate LTP/LTD impairment with memory impairment since it is not possible to check directly this 
condition. LTP-like synaptic plasticity events are likely to mediate hippocampal learning and memory 
but it is important to keep in mind that it can be through other long term changes in several 
hippocampal areas or even phenomena concerning metaplasticity. 
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Part III | Section 3 – Object Recognition Memory 
  
Recognition memory refers the capacity of recognizing someone or something that was 
presented previously. This is a subcategory that belongs to the declarative memory and is a very 
important feature that is widely viewed as composed by two components: recollection and familiarity 
(Squire et al., 2007). These two components, according to Brown and Aggleton (2001), are thought to 
be dependent on two different brain structures. The recollection, which is defined as the capacity to 
remember specific contextual details about a previous learning episode is proposed to be dependent on 
hippocampus and on other hand, familiarity, the simple ability to remember the previous presented 
item without any specific info additional information about that learning episode (without 
recollection), is proposed to be dependent on the adjacent perihinal cortex (Squire et l., 2007; Brown 
and Aggleton, 2001).  
Although the controversial in the field regarding which of the areas is important for a specific 
functions, hippocampus is mainly accepted as of most importance in recognition memory (Squire et 
al., 2007). 
In the experimental context, depending on the organism of study, several memory tests can be 
used to access this kind of episodic memory. For instance, in rodents, based on the fact that these 
animals prefer novelty over to familiarity (a fact that is considered as existence of memory of a 
previous encountered item) it is possible to perform an object recognition task. In this task, animals 
will explore a field environment with two identical objects. After a delay from minutes to hours, the 
same environment is re-presented with a novel object substituting one of the previous objects. The 
preference of the novel object will be traduced in more time exploring that novel object without 
differences in the total exploration of both objects. With this time measurements it is possible to 
calculate a discrimination index (DI) that is close to one when there is a good performance (high 
exploration of the  novel object) or close to zero when there is a bad performance (low exploration of 
the  novel object)  (Figure 27).  
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FIGURE 27 – SCHEMATIC REPRESENTATION OF THE OBJECT RECOGNITION TASK. After a period of 
habituation, usually 24 hours before the training phase, the mice will be exposed to two identical objects. After this 
phase, one of the objects will be changed and the time spent exploring the new object will be evaluated by the 
discrimination index (DI). Another parameter that must be taken in consideration is the total exploration time of the 
objects that must remain the same for both training and test. Novel object (N); Familiar Object (F).  
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Part III | Section 3 – Astroglial CB1 and Object Recognition Memory 
 
The actual expression of CB1 receptor on brain astrocytes was a great matter of debate until 
very recently (Navarrete and Araque, 2008, 2010; Han et al., 2012). The role of the Astroglial CB1 
receptor in brain physiology remains largely unknown. Although it has been implied in the synaptic 
physiology and metabolism in the hippocampus through pharmacological approaches (Duarte et al., 
2012; Navarrete and Araque, 2008, 2010, Min and Nevian, 2012) only recently, through the generation 
of a conditional knockout model, It was possible to anatomically detect its presence in astrocytes 
through electron microscopy (Han et al., 2012). The generation of this conditional Knockout model by 
the host laboratory was used by Han and colleagues to show that exogenous cannabinoids impair 
working memory through astroglial CB1 receptor possible by the induction of a hippocampal 
cannabinoid mediated-LTD (Han et al., 2012). Notably, this study uncovered a first role of astroglial 
CB1 receptor in behavioral, cognitive functions, underlining the importance of this genetic tool to 
study its role in vivo, which, however, still remains largely unknown. In particular, Han and colleagues 
described a memory-related mechanism that is induced by exogenous activation of astroglial CB1. 
Nevertheless, the endogenous role of astroglial CB1 receptor in memory processing is not known so 
far. 
Interestingly, unpublished results from the host laboratory show that the Astroglial CB1 
receptor is necessary for object recognition memory because mice lacking the astroglial CB1 display 
strong recognition memory impairment (Metna-Laurent, Unpublished Data). 
Intracellular Astroglial CB1R action mechanism is proposed to be through a Gq coupled to PLC 
that mobilize and increases calcium levels in hippocampal astrocytes (Navarrete and Araque, 2008). 
This increase is thought to mediate the release of gliotransmitters that can act in the synapse leading to 
the modulation of both short and long term synaptic plasticity. Long term synaptic changes are 
strongly associated with memory functions. As it was discussed previously during the introduction 
(Part III, Section 2), NMDAR-dependent transmission is one of the molecular mechanisms proposed to 
underlie object recognition memory in hippocampus. The further involvement of the NMDAR 
transmission in Object Recognition memory was tested with the injection of AP-5 in the dorsal 
hippocampus of C57BL/6N. This treatment is able to impair object recognition memory, confirming 
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that NMDAR transmission in hippocampus is necessary for intact Object Recognition Memory (Robin 
et al., Unpublished Data).  
One of the molecules that are known to potentiate specifically NMDAR-dependent synaptic 
changes is D-Serine. This molecule, as it was widely spoken during the introduction, is thought to be 
released by astrocytes during synaptic activity maybe in a calcium-dependent way (Henneberger et al., 
2010).  Taking in consideration the putative calcium-dependent release of gliotransmitters by 
astrocytes, it is possible to speculate that endogenous Astroglial CB1 could control object recognition 
memory by favoring D-Serine availability in the synapse. Strikingly, the injection of D-Serine either 
i.p or directly in the hippocampus is able to fully and specifically rescue the object recognition 
impairment of the GFAP-CB1-KO mice. Altogether, these preliminary results indicate that 
endogenous astroglial CB1 receptor signaling controls object recognition memory through a 
mechanism that depends on hippocampal NMDAR transmission and that can be mimicked by 
exogenous administration of D-Serine (Robin et al., Unpublished results).  
After these behavioral experiments, the host laboratory decided to investigate putative 
molecular mechanisms underlying this memory impairment. In vitro electrophysiology recording from 
hippocampal slices, the Astroglial CB1 receptors deletion does not change neither long term 
potentiation neither long term depression at CA3-CA1 synapses (Langlais et al., unpublished data). 
Nevertheless it is important to keep in mind that the aggressive procedure used to prepare the slices 
may damage or impair astrocyte function in these experiments (Aston-jones and Siggins, 2000) 
Nevertheless, the role of the astrocytic CB1 receptor must be further investigated in vivo experiments 
to seek for mechanisms that may underlie object recognition memory. 
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Part IV – Research Objectives 
 
Long term changes in synaptic plasticity are believed to underlie complex functions in behavior 
such as learning and memory (Neves et al., 2008). The endocannabinoid system is a major modulator 
of several neural functions and behavior by through direct influence on the synaptic functions (Castillo 
et al., 2012). The cannabinoid receptor 1 is present across the whole brain (Kano et al., 2009). In the 
hippocampal formation, CB1 receptor is widely distributed, being present in much higher level in 
GABAergic interneurons than in glutamatergic pyramidal neurons (Kano et al., 2009). Although the 
presence of CB1 in astrocytes has been suggested through functional studies (Navarrete and Araque, 
2008; 2010), only recently it has been observed and quantified through immunoelectron microscopy 
(Han et al., 2012). Evidence from the past decade established that astrocytes play a pivotal role in the 
control of synaptic plasticity. The evidence connecting the ECS, the astrocytes and the regulation of 
changes in synaptic plasticity and physiology in hippocampal networks may be of the most importance 
for the regulation of complex brain functions. 
Recently it has been shown that astroglial CB1 is necessary for object recognition memory 
(Metna-Laurent et al., unpublished data) and that this impairment is rescued by either systemically and 
local injection of the NMDAR co-agonist, D-Serine. Object recognition memory depends on NMDAR 
transmission since the intra hippocampal administration of NMDAR specific antagonist AP-5 can 
elicit e ORM impairment (Robin et al., unpublished data). Altogether these findings suggested that 
astroglial CB1 receptor deletion impairs NMDAR through the decreased occupancy of their co-
agonist-binding site (Robin et al., unpublished data). 
The general objective of this thesis work is to uncover cellular mechanisms by which 
Astroglial CB1 receptor could control object recognition memory. 
 To achieve my objective I used in vivo electrophysiology combined with genetic and 
pharmacological approaches to investigate the synaptic functions of CB1 receptor on astrocytes in the 
CA3-CA1 Schaffer Collateral Pathway in the hippocampus.  
In the first part of my project, I searched for a protocol that could induce a stable and 
consistence long term potentiation in wild type mice. In the second part, we used the selected protocol 
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to study the consequence of the absence of astroglial CB1 receptor on in vivo long term potentiation in 
mice were Astroglial CB1 receptors were absent.  
Conclusions from this work show that deletion of the astroglial CB1 receptor leads to an 
impairment of long term potentiation in a NMDAR transmission -dependent manner. Furthermore, my 
results show that the same dose of exogenous D-Serine that can rescue the memory impairment in 
mice lacking the astroglial CB1 receptors is also sufficient to rescue the in vivo long term potentiation 
impairment induced by astroglial CB1 deletion. Altogether these results fuel the growing concept that 
Astroglial transmission through endocannabinoid signaling is crucial for synaptic plasticity phenomena 
ultimately underlying complex brain functions such as learning and memory. 
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Chapter II – Material and Methods 
 
Animal Procedure Approval 
 
Experiments were approved by the Comité d’Éthique pour l’Expérimentation Animale 
Bordeaux under the responsibility of the Comité National de Réflexion Ethique sur l´Expérimentation 
Animale of France (authorization number 50120117-A).  
 
Animals 
 
The GFAP.CB1 conditional mutants used were aged between 12 and 14 weeks old and were 
bred in the animal facilities of NeuroCentre Magendie (Bordeaux). They were maintained in rooms at 
22–23°C with a light/dark cycle from (lights on from 7:00 A.M. to 7:00 P.M). They were housed 
individually one week before the experimental period where water and food was available ad libitum. 
Adult male GFAP.CB1.KO transgenic mice were generated as described in Han et al., 2012. 
Due to the fact that GFAP.CB1 are a conditional mutant mouse line in which the CreERT2 protein is 
inactive in the absence of Tamoxifen treatment, the deletion of CB1 receptors in mice (7-8 weeks-old) 
is achieved by an eight days treatment of Tamoxifen (1 mg; i.p.) dissolved in 90% sesame oil and 10% 
ethanol to a final concentration of 10 mg/ml (Hirrlinger et al., 2006). The animals were used after a 
period of 3 to 4 weeks from the end of the treatment. The absence of the CB1 protein in GFAP 
expressing cells in hippocampus from GFAP.CB1.KO was accessed by double immunohistochemistry 
for electron microscopy (Han et al., 2012). All experimental animals were littermates. Each animal 
was genotyped before and after the experimental procedure from a tail biopsy by genomic PCR as 
described before (Marsicano et al. 2003). This procedure is achieved by the genotyping facility of 
NeuroCentre Magendie (Bordeaux). 
The role of Astroglial Type 1 Cannabinoid Receptor in Memory Functions 
65 
José Fernando Oliveira da Cruz – Universidade de Coimbra (2013) 
 
In Vivo Electrophysiology in Anesthetized Mice 
 
GFAP.CB1.WT and GFAP.CB1.KO mice were anesthetized in a box containing 5% Isoflurane 
before being placed in a stereotaxic frame with their nose in an anesthetic mask, in which 1, 5% of 
Isoflurane was continuously supply during the complete duration of the experiments. The mice’s body 
temperature was maintained using at 37°C using a temperature control system. 
 
A longitudinal incision of 1.5 cm in length was made in the midline of the scalp, followed first 
by exposing the skull, including the Lambda and Bregma. After drilling two holes in the skull, one 
recording electrode was inserted in the CA1 region and one stimulation electrode was inserted either in 
Ventral Hippocampal Commissural (VHC) or CA3 regions with the following coordinates: 1) CA1 
stratum radiatum: A/P -1.5 mm, M/L -1.0 mm, DV 1.20 mm; 2)VHC: A/P -0.5 mm, M/L 0.3, DV 2.8; 
CA3: A/P -2.5 mm, M/L -2.8, D/V -2.0 mm. A general representation is shown in figure 28. The 
recording electrode was a glass recording electrode (tip diameter = 2–3 μm, 4–6 MΩ) filled with a 2% 
FIGURE 28 – SCHEMATIC REPRESENTATION OF IN VIVO STIMULATION AND RECORDING FROM THE 
IPSILATERAL CA3-CA1 SCHAFFER COLLATERAL PATHWAY. Dorsal (D), Medial (M), Lateral (L), Ventral 
(V), Recording Electrode (Rec), stimulation electrode (St), Subiculum (Sub) (From Clarke et al., 2010). 
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pontamine sky blue solution in 0.5 M sodium acetate. At first the recording electrode location was 
placed by hand until it reached the surface of the brain and then by automatic micrometer to ensure 
accuracy. The stimulation electrode was placed in the correct place only by hand. Both electrodes were 
adjusted to find the correct area. In vivo recordings of field excitatory postsynaptic potentials (fEPSPs) 
were amplified 10 times by the Axoclamp2B amplifier were further amplified 100 times and filtered 
(low-pass filter at 300 Hz) via a differential AC amplifier (model 1700; A-M Systems, Carlsborg, 
WA). fEPSPs were digitized and collected on-line using a laboratory interface and software (CED 
1401, SPIKE 2; Cambridge Electronic Design). 
a square pulse stimulator and stimulus isolator (DS3; Digitimer, Hertfordshire, UK), and collected 
every 5 s at a 10 kHz sampling frequency and then averaged every 200 sec. Basal stimulation intensity 
was adjusted to 30-40% of the current intensity that evoked a maximum field response. The slope of 
the fEPSP was used to generate an input-output curve (I/O) relationship ranging from sub threshold to 
maximal response. All responses were expressed as percent change from the average responses 
recorded during the 10 min before high frequency stimulation. High frequency stimulation was 
induced by applying 1 train or 3 trains of 100 Hz (1 sec each), (the 3 trains being separated by 20 
seconds interval). fEPSP were recorded for a period of 40 minutes. In another group of mice, the 
following treatments were applied: 1) MK 801 injection (Abcam, Cambridge, UK; 3.0 mg/kg i.p. 
dissolved in saline, one hour before HFS) or vehicle (physiological saline, i.p., 2-3 hours before HFS) 
2) D-Serine injection (Abcam, Cambridge, UK; 50.0 mg/kg i.p. dissolved in physiological saline) 2-3 
hours before HFS or vehicle (physiological saline, i.p., 2-3 hours before HFS). 
 
Histology 
 
At the end of each recording experiment, the electrode placement was marked with an 
iontophoretic deposit of pontamine sky blue dye (-20 A, continuous current for 12-15 min). To mark 
electrical stimulation sites, 10 A of positive current was passed through the stimulation electrode for 
1 minute. After the experimental procedures, the animals were deeply anesthetized with Isoflurane 
(5%) and decapitated. Brains were removed and snap-frozen in a solution of Isopentane at -70C. The 
brains were sectioned into 70 μm-thick coronal slices for histological determination of recording and 
stimulating electrode sites. 
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Statistical Analysis 
 
Results are expressed throughout as means ± SEM. In multiple comparisons, values were 
subjected to a two-way ANOVA followed by Bonferroni post-hoc test. Statistical significance was set 
at p< 0.05. 
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Chapter III – Results  
 
 
 Preliminary results 
 
Long term synaptic changes such as long term potentiation are thought to underlie complex 
brain functions such as learning and memory (Hu et al., 2011). In the hippocampus, the long term 
potentiation induced in the CA3-CA1 Schaffer Collateral pathway is one of the most well studied 
phenomena concerning synaptic plasticity. In this model, the stimulation of CA3 axons with a certain 
intensity and frequency can induce long term changes in the CA1 synapses. As it was discussed 
previously in the introduction, the astroglial CB1 receptor deletion causes a strong recognition memory 
impairment that is dependent on NMDAR transmission and that can be reversed by either systemically 
or hippocampal administration of D-Serine, a NMDAR co-agonist. In attempt to determine the 
mechanisms underlying these behavioral data, we decided to use in vivo electrophysiology to evaluate 
the synapse functionality of the Schaffer Collateral pathway after deletion of astroglial CB1 receptors 
in the GFAP.CB1.KO mice. 
First, we decided to search for an effective HFS protocol that could induce a stable LTP in 
GFAP.CB1 mice. It is known that CA3 pyramidal neurons can synapse with themselves, ipsilaterally 
with CA1 and contralaterally with CA1 via the Ventral hippocampal Commissure (VHC) (Witter, 
2007). It is known that LTP can be induced at CA1 synapses by directly stimulating the contralateral 
VHC instead of the CA3 (Vouimba et a., 2013). We thus applied this protocol which was also more 
convenient in our experimental setting than both stimulating and recording at the same brain 
hemisphere (i.e. bigger gap between both electrodes). 
In this preliminary experiment, we searched for an optimal protocol for LTP induction. We 
used a classical HFS protocol of 1 train of 100 Hz (1s) that is known to induce long term potentiation 
in CA3-CA1 pathway (Ris et al., 2007). As we can see in Figure 29A and B, 40 minutes after HFS, the 
protocol used is not able to persistently increase fEPSCs neither in tamoxifen-treated GFAP.CB1.WT 
(111.6 ± 22.75, as compared to 100, n=7), nor in GFAP.CB1.KO (264.4 ± 96.54, as compared to 100, 
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n=9; F1,28 = 1.79, p > 0.05). As this protocol could not induce synaptic potentiation in the WT 
littermates, we decide to increase the intensity of stimulation thereby trying a stronger protocol. 
In the second preliminary experiment, we decide to apply a HFS protocol of 3 trains of 100Hz 
(1s) separated apart by 20 seconds to induce LTP (Blitzer et al., 1995). With this protocol, the 
tamoxifen-treated GFAP.CB1.WT mice are able to induce an increase over baseline although they 
cannot sustain it during the 40 minutes period (106.9 ± 23.63, as compared to 100, n=9) (F1,15=0.22, 
p>0.05)  (Figure 29C and D). GFAP.CB1.KO mice were not able to induce changes over baseline 
(96.54 ± 15.93, as compared to 100, n=8). Because this protocol was not able to induce a potentiation 
in the GFAP.CB1.WT we decided to overcome the technical limitations described above and to change 
the stimulation/recording areas to the ipsilateral CA3-CA1 pathway (Clarke et al., 2010). 
The role of Astroglial Type 1 Cannabinoid Receptor in Memory Functions 
70 
José Fernando Oliveira da Cruz – Universidade de Coimbra (2013) 
FIGURE 29 – PRELIMINARY DATA. (A) Plots of normalized fEPSP slopes in anesthetized mice show 
that 1 train of 100Hz (1s) is not able to induce long term potentiation in VHC -CA1 synapses from 
GFAP.CB1.WT littermates although inducing long term potentiation GFAP.CB1.KO mice. (C) Plots of 
normalized fEPSP slopes in anesthetized mice show that 3 train of 100Hz (1s) is also not able to induce 
long term potentiation in VHC-CA1 synapses from neither GFAP.CB1.WT littermates or from 
GFAP.CB1.KO. Representative fEPSP traces before (1) and 40 min after (2) high frequency stimulation 
(HFS) are shown above the plot. (B and D) Histograms summarizing the average percent changes of fEPSP 
slope in baseline (1) and 40 min after (2) HFS of A and D, respectively. 
All summary graphs show means ± S; n = numbers of animals recorded (A, B) in each group. Two -way 
ANOVA (B: F1,28 = 1.79, p > 0.05; D: F1,15 = 0.22, p > 0.05). 
 
  
  
A B 
D C 
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Astroglial CB1 receptors are necessary for in vivo long 
term potentiation in CA3-CA1 synapse 
C D 
FIGURE 30 - ASTROGLIAL CB1 RECEPTORS ARE NECESSARY FOR IN VIVO LONG TERM POTENTIATION IN 
CA3-CA1 SYNAPSES.  (A) Plots of normalized. fEPSP slopes in anesthetized mice show that 3 trains of 100Hz (1s) are 
able to elicit long term potentiation in wild-type (GFAP-CB1-WT) but not in  GFAP-CB1-KO mice. Representative 
fEPSP traces before (1) and 40 min after (2) high frequency stimulation (HFS) are shown above the plot. (B) Histogram 
summarize the average percent changes of fEPSP slope in baseline (1) and 40 min after (2) HFS. (C and D) Histological 
control for the recording electrode (C) and for the stimulation electrode (D). The scale bar represents 50 mm. All 
summary graphs show means ± SEM; n = numbers of animals recorded (A, B) in each group. **p < 0.01 versus control, 
Bonferronni post-hoc test after two-way ANOVA (B: F1,13 = 6.24, p < 0.05). 
 
A 
B 
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In vivo recordings of field excitatory postsynaptic potentials (fEPSP) from CA3-CA1 synapses in 
anesthetized mice shows that tamoxifen-treated wild-type mice littermates were able to induce and maintain a 
constant potentiation finishing after 40 min with an increase over baseline close to 40% (137,7 ± 15.97, as 
compared to 100, n=9) (Figure 30 A, B). fEPSP from GFAP.CB1.KO mice do not show changes over baseline 
during the all  40 minutes after HFS, even showing a small decrease (87.76 ± 7.36, as compared to 100, n=6) 
(Figure 30 A and 2B). This fEPSP recorded from the GFAP.CB1.KO is significantly different from the 
GFAP.CB1.WT littermate mice (F1,13 = 6.24, **p<0.01). Therefore, astroglial CB1 receptors deletion in the 
GFAP-CB1-KO prevent LTP induction in CA3-CA1 hippocampal synapses in vivo. Mice in which the 
recording electrode didn’t target the stratum radiatum of CA1 and mice in which the stimulation electrode didn’t 
target the CA3 axons were excluded from analysis (figure 30 C, D). As this LTP induction procedure proved to 
be effective in WT littermates in our experimental conditions, further analyses were conducted using the same 
areas of stimulation/recording. 
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Astroglial CB1 dependent long term potentiation is mediated by 
NMDAR transmission 
 
 
Previous data from the host laboratory indicates that the blockade of hippocampal NMDAR by 
AP-5, an antagonist acting on the glutamate binding-site (Paoletti & Neyton, 2007), is able to impair 
object recognition memory in wild-type mice, showing that this form off memory is both dependent on 
astroglial CB1 receptors and on NMDAR transmission in the hippocampus (Robin et al., unpublished 
results). Since the LTP phenomenon in the hippocampus is thought to participate in object recognition 
memory (Ennaceur, 2010), we propose to examine whether the astroglial CB1-dependent hippocampal 
LTP in vivo described before share the same mechanisms as the astroglial CB1-dependent object 
recognition memory process. We thus hypothesized that the LTP observed in tamoxifen-treated wild-
type mice littermates from the previous experiment is also NMDAR dependent. In order to test our 
A B 
FIGURE 31 - ASTROGLIAL CB1 DEPENDENT LONG TERM POTENTIATION IS MEDIATED BY NMDAR 
TRANSMISSION. (A) PLOTS OF NORMALIZED FEPSP SLOPES IN ANESTHETIZED MICE SHOW THAT THE I.P. 
INJECTION OF 3.0 MG/KG MK 801 ONE HOUR BEFORE HFS IS ABLE TO ABOLISH LONG TERM POTENTIATION IN 
GFAP.CB1.WT MICE. REPRESENTATIVE FEPSP TRACES BEFORE (1) AND 40 MIN AFTER (2) HIGH FREQUENCY 
STIMULATION (HFS) ARE SHOWN ABOVE THE PLOT. (B) HISTOGRAM SUMMARIZES THE AVERAGE PERCENT 
CHANGES OF FEPSP SLOPE IN BASELINE (1) AND 40 MIN AFTER (2) HFS. All summary graphs show means ± 
SEM; n = numbers of animals recorded (A, B) in each group. *p < 0.05 versus control, Bonferronni post -hoc 
test after two-way ANOVA (B: F1,6 = 3.36, p < 0.05). 
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hypothesis, we injected systemically MK 801 (3 mg/kg; i.p.), a specific non-competitive antagonist of 
the NMDA receptor wildly used systemically in in vivo experiments (Zhang et al., 1992), before the 
HFS procedure.  
As it is illustrated in figure 31A, the systemic treatment with MK 801 (3 mg/kg), one hour 
before HFS, is able to fully impair LTP in the tamoxifen-treated GFAP.CB1.WT (92.54 ± 6.16, as 
compared to 100, n=3) as compared with vehicle treatment (214.9 ± 49.03, as compared to 100, n=5) (F1,6 
= 3.36, p < 0.05) (Figure 31A and B). The results support our hypothesis indicating that long term 
potentiation observed in GFAP.CB1.WT is dependent of NMDAR transmission. 
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Exogenous D-Serine rescues in vivo long term potentiation impairment 
induced by Astroglial CB1 deletion 
 
 
 
 
A 
FIGURE 32 - EXOGENOUS D-SERINE RESCUES IN VIVO LONG TERM POTENTIATION IMPAIRMENT INDUCED BY 
ASTROGLIAL CB1 DELETION. (A-C) Plots of normalized fEPSP slopes in anesthetized mice show that the i.p. injection 
of D-Serine (50 mg/kg) rescues the long term potentiation impairment observed in the GFAP.CB1.KO mice. Representative 
fEPSP traces before (1) and 40 min after (2) high frequency stimulation (HFS) are shown above the plot. (D) Histogram 
summarizes the average percent changes of fEPSP slope 40 min a fter HFS. All summary graphs show means ± SEM; n = 
numbers of animals recorded (A, B) in each group. *p < 0.05, **p < 0.01 Bonferronni post -hoc test after two-way ANOVA 
(D: F1,19 = 9.75, p < 0.05). 
 
 
 
D 
B 
C 
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Following unpublished results from Robin et al., we hypothesize that the same D-Serine dose 
that is able to restore a normal long-term OR memory in GFAP.CB1.KO is also capable of rescuing  
the NMDAR dependent long term potentiation impairment observed in GFAP.CB1.KO mice. To test 
this hypothesis we injected 50 mg/kg of D-Serine between two and three hours before HFS in 
GFAP.CB1.KO mice and WT littermates. The time window chosen took in consideration the time 
necessary for exogenous D-Serine to pass the blood brain barrier thereby achieving the highest levels 
in the brain (Pernot et al., 2012). 
 In vivo recordings of field excitatory postsynaptic potentials from GFAP.CB1.KO mice and 
WT littermates after vehicle treatment confirmed the results obtained in the first set of experiments: 
GFAP.CB1.WT mice are able to induce and maintain a potentiation 40 minutes after HFS (214.9 ± 
49.03, as compared to 100, n=5) and significantly different (p<0.01) from GFAP.CB1.KO mice which 
showed no LTP induction (72.15 ± 5.2, as compared to 100, n=7) (Figure 32 A). Strikingly, 
GFAP.CB1.KO mice treated with D-Serine are able to clearly rescue the LTP impairment (197.3 ± 
39.10, as compared to 100, n=5) shown in GFAP.CB1.KO mice treated with vehicle (Figure 32 B and 
C). The long term potentiation exhibited is not significantly different neither from WT D-Serine 
treated littermates (151.4 ± 24.42, as compared to 100, n=6) (p>0.05) or from vehicle treated WT 
littermates (p>0.05) (Figure 32 D). These results indicate that the exogenous i.p. injection of 50 mg/kg 
of D-Serine can rescues in vivo long term potentiation impairment induced by astroglial CB1 deletion 
potentially through a NMDAR dependent mechanism. 
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Chapter IV – Discussion  
 
Our results indicate that the cannabinoid receptor 1 on astrocytes is essential for the regulation 
of hippocampal synaptic plasticity. We found that the astroglial CB1 is necessary for the induction of a 
NMDAR-dependent long term potentiation in CA3-CA1 synapses. Furthermore we show that this 
impairment can be rescued through the systemic injection of D-Serine, a NMDAR co-agonist. 
Altogether these results support the growing idea that endocannabinoid-mediated neuron-astrocyte 
communication through the astroglial CB1 plays a key role in the modulation of hippocampal synaptic 
plasticity that ultimately may underlie learning and memory.  
The hippocampus being crucial for object recognition memory, electrophysiological studies in 
this area may provide important insights to study elicited changes in synaptic plasticity (Ho et al., 
2011). To investigate the potential role of astroglial CB1 in hippocampal synaptic plasticity, Valentin 
Langlais in Dr Oliet’s laboratory used in vivo electrophysiology on brain slices to examine changes in 
long term synaptic plasticity in the CA3-CA1 Schaffer Collateral Pathway. Interestingly, there were no 
differences between genotypes concerning input/output curves or in the ratio between NMDARs and 
AMPAR currents in the mutants. Both mutant and wild type littermates did not elicited changes neither 
in long term potentiation or long term depression. These results suggest that astroglial CB1 does not 
alter basic properties of glutamatergic transmission in CA1 synapse from Schaffer Collaterals pathway 
in brain slices.  
 Because astrocytic properties in vivo may differ from in vitro or cultures properties, we 
decided to check the same pathway in vivo. Astroglial CB1 receptors signaling did not alter NMDAR-
dependent long term potentiation in a protocol requiring endogenous D-serine release from astrocytes 
on brain slices (Henneberger et al.), However, in our study, mice lacking astroglial CB1 cannot induce 
long term potentiation in vivo using a similar induction protocol. These striking results show that 
astroglial CB1 is necessary for in vivo long term synaptic plasticity. These apparent contrasting results 
in in vivo and in vitro electrophysiological approaches can be explained by several technical 
distinctions between both procedures. 
First of all, the slice preparations (e.g. cutting the brain) may disrupt neuronal and astroglial 
networks that may support synaptic functions during the high frequency stimulation. Similarly, the 
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cannabinoids-induced, astroglial CB1 receptor -dependent long term depression can be observed in 
vivo (Han et al., 2012) but not on brain slices (Chevaleyre and Castillo, 2006). Indeed, the impact of 
astroglial CB1 receptor on synaptic plasticity might be masked on brain slices if this control involves 
an extended network processing. It is know that astrocytes communicate among themselves and 
display huge calcium waves that can travel over several microns (Kuga et al., 2011). In this context, 
we do not know to which extend the slice preparation may disrupt these connections and thereby mask 
a possible astrocytic global and not local modulation over the glutamatergic synapses through, for 
example, the trafficking of molecules and ions (Giaume et al, 2010). 
Another important issue is to take in consideration that the slices suffer from a huge insult 
when they are cut. In this period they must recover before recording and they are kept in an artificial 
environment with not physiological temperatures (room temperature) that may alter intrinsically 
properties of astrocytes that are still poorly understood and many times not taken in consideration 
(Aston-jones and Siggins, 2000).  
Another important fact is that in slices, there is inhibition of GABAergic transmission through 
bath application of Picrotoxin which is a noncompetitive antagonist for GABA A receptors (Olson and 
DeLorey, 1999). This objective of this inhibition is to record more specifically glutamatergic 
excitatory currents without being contaminated with GABAergic inputs (Verdier et al., 2004). In in 
vivo electrophysiology it is not possible to fully inhibit the GABAergic transmission and this issue 
must be taken in consideration. It would be interesting to redo electrophysiology in slices but this time 
without Picrotoxin to check if there is a different phenotype. Another interesting experiment still more 
technically difficult would be to inhibit in vivo GABAergic transmission through a local injection of 
Picrotoxin and check whether there are changes in the phenotypes obtained. The technical difficulty 
relies on the fact that there is no established evidence of this inhibitor in in vivo electrophysiology. 
Problems with drug diffusion and lack of specificity may blur possible results. Still, it would be 
interesting to check possible outcomes within in scenario. Independently, we must take in 
consideration a possible of role GABAergic transmission in the whole process of astroglial CB1-
dependent synaptic transmission. 
Robin et al., (unpublished data) demonstrated that hippocampal NMDAR transmission is a 
necessary component for object recognition memory. Our results show that after the injection of an 
NMDAR antagonist, MK 801, the long term potentiation elicited in wild type littermates is completely 
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abolished, thus allowing the conclusion that NMDAR transmission is directly involved in the astroglial 
CB1-dependent long term potentiation.  
Calcium increase in astrocytes is believed to underlie gliotransmission mechanisms (Agulhon 
et al., 2012). The astroglial CB1 receptor has been proposed to act through a Gq protein that is coupled 
to a PLC that can mobilize calcium stores inside astrocytes (Navarrete and Araque 2008, 2010). D-
Serine is believed to be docked in the membrane of astrocytes and readily available to be released 
(Martineau et al., 2013). Nevertheless, it has also been shown that abolishing calcium mobilization in 
astrocytes can impair LTP through the reduction of the NMDAR co-agonist occupancy levels 
(Henneberger et al., 2010). In our study, we show that D-Serine administration can rescue the 
NMDAR-dependent long term potentiation impairment in mice lacking Astroglial CB1. Within this 
scenario where exogenous D-Serine rescues the phenotype observed in the conditional KO, and 
following the functional studies from Navarrete and Araque (2008, 2010), it is possible to theorize that 
astroglial CB1 receptor signaling leads to a calcium rise in astrocytes that possibly underlies the 
release of D-Serine. This D-Serine would then participate in the NMDAR-dependent long term 
potentiation by increasing the occupancy levels of the NMDAR co-agonist binding sites, leading to a 
more efficient and stronger activation of NMDAR. 
Recently, it has been proposed that endocannabinoids can bind to astroglial CB1 receptors in 
CA1 astrocytes from brain slices, thus increasing calcium concentrations inside astrocytes. This 
increase stimulates the release of glutamate into the presynaptic terminal that will act on metabotropic 
glutamate receptor type 1 leading to the release of glutamate (Navarrete and Araque, 2008, 2010). In 
2012, Han et al., described a mechanism in which the exogenous administration of cannabinoids can 
induce an NMDAR –dependent LTD in CA3-CA1 synapses in vivo. These apparently contradictory 
results must take in consideration the fact the exogenous cannabinoids used by Han and colleagues 
may mask the locally and spatially –controlled “on demand” (Piomelli, 2003; Marsicano et al., 2003) 
release of endocannabinoid, a tightly regulated endogenous mechanism that can lead to different 
physiological phenomena.  
Taking in consideration an endogenous point of view, it is possible to conjecture that the 
release of D-Serine acting in NMDA receptors may potentiate the excitatory glutamatergic synapses 
during high frequency stimulation. Nevertheless, more studies are needed to further investigate the 
possible mechanism underlying this long term potentiation. 
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One key experiment to confirm this hypothesis of astrocytic modulation of synaptic plasticity 
through the release of D-Serine would be the direct measurement of Glycine and D-Serine levels either 
in vitro (in primary cultures of hippocampal astrocytes WT and lacking CB1 receptors) or in vivo 
through intrahippocampal microdialysis in freely moving mice performing the object recognition task, 
which would be the ideal experimental condition, albeit technically more difficult. If our hypothesis is 
correct, the stimulation of WT primary astrocytes by, for instance, increasing bath calcium 
concentration, would lead to a specific increase of the extracellular concentrations of D-Serine as 
compared to as compared to other amino acid, a phenomenon which would be blocked in CB1-KO 
astrocytes. In in vivo experiments, it would be expectable a similar conclusion. In WT it would be 
predictable that D-Serine levels would increase after ORT as compared to naive mice and this increase 
would not be seen in littermate mice lacking astroglial CB1 receptor. 
Recently it has been proposed that synaptic and extrasynaptic NMDAR are gated by different 
endogenous co-agonists (Papouin et al., 2012). In this context, extrasynaptic GluN2B-NMDAR 
heteromers have higher affinity to Glycine where synaptic GluN2A-NMDARs heteromers have 
stronger affinity for D-serine (Papouin et al., 2012). These conclusions merged together with our study 
may raise the following question: is D-Serine the required NMDAR co-agonist or the high levels of D-
Serine mask a putative effect featured by glycine? Glycine being a primary inhibitory neurotransmitter 
in the spinal cord and brainstem, the in vivo administration of this molecule produces bradycardia and 
may not be compatible with anesthetize organisms during the long period of recording (Olsson and 
Hahn, 1999). One of the strategies to overcome these issues concerning exogenous administration of 
glycine would be the regulation of endogenous levels by inhibition glycine uptake through glycine 
transporter 1 inhibitors (Paoletti et al., 2013). This scenario should be tested both in in vivo 
electrophysiology and object recognition task. Nevertheless studies with co-administration of D-Serine 
and a GluN2A-NMDAR/GluN2B-NMDAR specific antagonist would provide less background and 
more answers regarding this issue. In this context it would be interesting to test, during object 
recognition task, the effect of co-administration of D-Serine with either a specific inhibitor of 
GluN2B-NMDAR heteromers (such as Ro 25-6981 (Fischer et al., 1997)) or specific inhibitor of 
GluN2A-NMDAR heteromers (such as NVP-AAM077 (Neyton and Paoletti, 2006). This would give a 
more clear picture whether D-Serine rescues the object recognition impairment in mice lacking 
astroglial CB1through specific NMDAR heteromers. Furthermore, if D-Serine rescues the phenotype 
specifically through GluN2B-NMDAR heteromers, and following recent evidence showing that this 
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subunit has higher affinity for glycine as compared with D-Serine (Papouin et al., 2012), one could 
hypothesize that D-Serine may rescue the phenotype by overcoming defective glycine levels. This 
would give rise to more complex questions regarding the role of astrocytes in the control of glycine 
levels either spatially (synaptic vs. extrasynaptic) and temporally (basal levels or increase after 
induction of long term synaptic plasticity). Nevertheless is extremely important to keep in mind a 
broader view concerning co-agonist’s availability and NMDAR location, composition and function 
(Paoletti et al., 2013). 
Another interesting question concerns the role of neuronal CB1 in synaptic plasticity events. It 
is known that mice bearing a full deletion of CB1 receptors (full knockout) or mice lacking CB1 
receptor in GABAergic or Glutamatergic neurons do not display impairments in object recognition 
memory (Metna-Laurent, unpublished data). The production of endocannabinoid that previously acted 
on astroglial CB1 may redirect their targets after the induction of astroglial CB1 deletion. Although it 
has been shown that astroglial CB1 is necessary for both object recognition memory and the induction 
of a NMDAR-dependent long term potentiation, we don’t know in what extent neuronal CB1 may 
participate in the exhibited phenotypes. Equally it would be interesting to check in both in vivo 
electrophysiology and object recognition task if there are still the described phenotypes after 
administration of CB1 specific antagonist such as Rimonabant. Important insights concerning the 
selective role of neuronal and astroglial CB1, both in memory and synaptic plasticity, could be 
gathered from this experiment. 
Here we showed that astroglial CB1 receptor signaling control a form of in vivo hippocampal 
NMDAR–dependent long term potentiation that can be mimicked by exogenous D-serine 
administration when CB1 receptor on astrocytes are suppressed. Strikingly, these mechanisms are 
shared by the astroglial CB1 receptor –dependent object recognition memory (Robin et al., 
unpublished results) because normal (i.e. wild-type –like) behavioral performances in this task need an 
intact hippocampal NMDAR transmission and can be also restored by intra-hippocampal D-serine 
administration. Together, these results point to a scenario where astroglial CB1 receptor signaling 
controls object recognition memory by regulating NMDAR-dependent long term potentiation through 
the occupancy of their co-agonist-binding site. Although it is not possible to establish a direct 
correlation between an object recognition memory impairment and impaired long term potentiation, it 
is possible to assume that activity dependent synaptic changes are important to neuronal tasks (Neves 
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et al., 2008). In this context it would be interesting to check in mice lacking astroglial CB1 receptor 
through in vivo electrophysiology in awake mice performing ORT, if there are changes in synaptic 
strength between before training and after test 2 (Figure in 27). In a hypothetical scenario of a different 
phenotype, what would be the putative effect of D-Serine administration?  
It would be also important to check whether astroglial CB1 receptors modulate other synaptic 
plasticity processes. It has been reported that learning a new environment underlies a facilitation of 
hippocampal LTD, even without its induction (Manahan-Vaughan et al., 1999). In this context it would 
be interesting to investigate whether this form of long term synaptic plasticity is also impaired in mice 
lacking astroglial CB1. Another interesting experiment would be to check if other known hippocampal 
dependent memory functions are also impaired. Recently it has been reported that astrocytic signaling 
controls endocannabinoid mediated a spike timing-dependent long term depression (t-LTD) at 
neocortical synapses (Min and Nevian, 2012). It would be also interesting to check in a conditional KO 
whether astroglial CB1 is important in the induction of the astrocytic intracellular calcium 
concentrations that the authors described as essential for the induction of t-LTD.  
Another interesting point is the general network effect through the activation of CB1 on 
astrocytes. This effect could underlie possible impairments on glial-neuronal communication leading 
to lack of support of synapses that are under intense neuronal activity. Recently, through a functional 
study in rat hippocampal organotypic slices, it has been proposed that astrocytes contribute to a 
positive feedback loop that induces excessive neuronal discharge through an astroglial CB1 related 
mechanism (Coiret et al., 2012). Moreover, the authors propose that calcium increases spreading 
through the astrocytic networks are of the most importance in the modulation of epileptiform activity. 
D-Serine has been implied in epilepsy (Radzishevsky et al., 2012). Harai and colleagues reported that in 
Serine Racemase KO mice (Serine Racemase is responsible for D-Serine synthesis through the direct 
conversion of L-Serine) there is a partially resistant to seizures induced by a GABA antagonist, 
pentylenetetrazol (Harai et al., 2012). Since the over activation of the NMDA receptor has been 
implicated in the development of epileptic activity (Harai et al., 2012) and following the idea that 
astroglial CB1 may control D-Serine availability in glutamatergic synapses, it would be interesting to 
check whether astroglial CB1 conditional KO mice are resistant to induced epileptic seizures.  
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In general terms, all new evidence boosts the novel concept of astrocytes involvement in 
synaptic plasticity and also the concept of astroglial CB1 function in the modulation of synaptic 
plasticity. 
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Chapter V – Conclusion  
 
 
The results obtained during this study indicate that astroglial CB1 is an important component in 
the regulation of long term synaptic plasticity. Astroglial CB1 receptor is crucial for induction and 
maintenance of hippocampal NMDAR-dependent long term potentiation in the CA3-CA1 Shaffer 
Collateral pathway in vivo. Moreover, the systemic injection of the NMDAR co-agonist D-Serine is 
able to fully rescue the impaired LTP possibly due to the increase in the occupancy levels of the co-
agonist binding site in the NMDAR. Although it is not possible to imply directly LTP in memory 
performance, being long term synaptic changes believed to underlie learning and memory, it is 
possible to correlate the failure in the induction on long term potentiation with the object recognition 
memory impairment displayed by mice lacking CB1 receptors on astrocytes. Altogether these results 
boost the growing concept that endocannabinoid system is crucial for neuronal-glial bidirectional 
communication, participating in the astrocytic-dependent regulation of synaptic plasticity in 
hippocampal glutamatergic synapses that is accepted as a component of the molecular basis of memory 
processes.  
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